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1       Summary 
 
          Cardiovascular disease (CVD) is now the leading cause of death globally. Non-
modifiable risk factors of CVD mainly include advancing age, gender, ethnicity, and 
heredity. Major modifiable risk factors of CVD include hypertension, abnormal blood 
lipids, diabetes, obesity, and lifestyle-dependent factors such as physical inactivity, low 
fruit and vegetable diet, tobacco use and alcohol use. Other modifiable risk factors of 
CVD include low socioeconomic status (SES), mental illness, and use of certain 
medication. Environmental factors such as air temperature and air pollutions have also 
been linked with CVD. 
          Short-term exposure to heat has been related to cardiovascular mortality showing 
effects on the same day up to a three days delay. Cold usually showed four to 20 days 
delayed effects on cardiovascular mortality and morbidity. The exposure-response 
functions between mortality time-series and temperature measures have been shown to 
be U-, V- or J-shaped, and the range of temperature corresponding with a minimum 
mortality was reported to be related with latitude. There is less evidence about the 
adverse effects of elevated temperature on morbidity, supporting the hypothesis that 
many heat-related deaths occur in people before they come to medical attention. 
          Until today, most studies regarding temperature effects on health have been 
conducted in Europe and the United States; there is a lack of studies for Asian countries. 
I conducted a study in the urban area of Beijing, China, from January 2003 to August 
2005. I obtained daily CVD death counts, daily meteorological data as well as daily 
concentrations of ambient particulate air pollution. I estimated the effects of two-day 
and 15-day average temperatures on mortality by using Poisson regression models. I 
found that both increases and decreases in air temperature were associated with an 
increased risk of cardiovascular mortality in Beijing. The effects on adult (≥15 years) 
and elderly (≥65 years) residents were similar. The effects of heat were immediate, 
while the ones of cold became predominant with longer time lags. The associations were 
not confounded or modified by the order of the three warm periods included in the study, 
by heating in winter, or by ambient particulate air pollution. 
          There is increasing evidence for an association between ambient particulate matter 
(PM) and CVD during the last decades. PM is an exposure affecting the whole 
population; although the relative risk could be small, it still has a large public health 
impact. The exposure-response functions between short-term exposure to PM and 
cardiovascular mortality and morbidity are considered to be near-linear and without 
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threshold. Specific chemical compositions of PM are speculated to be responsible for 
the observed associations. Besides chemical composition, particle characteristics like size 
are discussed as important measures. Due to the limited availability of appropriate 
measurement data, there are only few epidemiological studies on short-term associations 
between daily cardiovascular mortality and morbidity and accurately size-segregated 
particles. 
          I conducted two analyses aiming at investigating how daily changes in ambient 
concentrations of size-segregated particles in Beijing, China, were associated with 
cardiovascular mortality and emergency room visit (ERV), respectively. I obtained daily 
CVD death counts and emergency room visit count data, accurately size-segregated 
particles data as well as meteorological data (potential confounder). I estimated the 
effects of particles of different size fractions on CVD mortality and morbidity by 
Poisson regression models including polynomial distributed lag (PDL) models. I found 
an elevated risk of two-day delayed cardiovascular mortality with the number 
concentration of sub-micrometer particles. And I found elevated risks for four- to ten-
day delayed cardiovascular emergency room visits in association with the number 
concentration of ultrafine particles (<100nm), as well as of current-day immediate 
cardiovascular emergency room visits with Aitken mode (30-100nm) and accumulation 
mode particles (100-1000nm). 
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2       Zusammenfassung 
 
          Kardiovaskuläre Erkrankungen stellen heute die weltweit führende Todesursache 
dar. Dabei handelt es sich um eine Erkrankung, die durch Arteriosklerose induziert wird 
(z. B. Herz-Kreislauf-Erkrankungen, Schlaganfall). Zu den nicht-beeinflussbaren 
Risikofaktoren für kardiovaskuläre Erkrankungen zählen hauptsächlich zunehmendes 
Alter, Geschlecht, Rasse oder ethnische Herkunft und Vererbung. Modifizierbare 
Risikofaktoren für kardiovaskuläre Erkrankungen sind hauptsächlich Bluthochdruck, 
anormale Blutfettwerte, Diabetes, Übergewicht und lebensstil-abhängige Faktoren, wie 
z.B. Bewegungsmangel, niedriger Obst- und Gemüse-Konsum, Tabakkonsum und 
Alkoholmissbrauch. Niedriger sozioökonomischer Status, psychische Erkrankungen und 
die Verwendung bestimmter Medikamente sind weitere modifizierbare Risikofaktoren 
für kardiovaskuläre Erkrankungen. Auch Umweltfaktoren, wie z.B. Temperatur und 
Luftverunreinigungen, sind mit kardiovaskulären Erkrankungen in Verbindung gebracht 
worden. 
          Kurzfristige Einwirkungen von Hitze können die kardiovaskuläre Mortalität 
sowohl am selben Tag, als auch mit einer Verzögerung bis zu drei Tage erhöhen. Die 
Expositions-Wirkungsbeziehung zwischen Mortalität und Temperatur werden häufig als  
U-, V- oder J- förmig beschrieben, wobei der Komfort-Bereich, in dem die Mortalität 
am niedrigsten ist, je nach geographischer Breite unterschiedlich sein kann. Negative 
Auswirkungen von erhöhter Temperatur auf die Morbidität sind nur durch wenige 
Studien belegt, was auch die Hypothese unterstützen könnte, dass viele Hitze-Todesfälle 
auftreten, bevor die Menschen in ärztliche Behandlung kommen. Kälte erhöht die 
kardiovaskuläre Mortalität und Morbidität mit einer Verzögerung von vier bis zu 
zwanzig Tage. Die Expositions-Wirkungsbeziehungen zwischen Mortalität oder 
Morbidität und Mehr-Tages-Mittelwerte der Temperatur werden als negativ linear 
beschrieben. 
          Bis heute sind die meisten Studien, die Temperatur-Auswirkungen auf die 
Gesundheit diskutiert haben, in Europa und den USA durchgeführt worden. Daher 
wurde von Januar 2003 bis August 2005 eine Studie im Stadtgebiet von Beijing, China, 
durchgeführt. Für diese Studie standen tägliche Anzahlen von kardiovaskulärer 
Mortalität, tägliche meteorologische Daten, sowie tägliche Konzentrationen von 
partikulären Luftschadstoffen (als potenzielle Störgrößen) zur Verfügung. Die 
Auswirkungen von 2-Tage- und 15-Tage-Mittelwerten der Temperatur auf die 
Mortalität wurden mit Hilfe von Poisson Regressionsmodellen geschätzt. Sowohl eine 
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Zu- als auch eine Abnahme der Lufttemperatur erhöhte das Risiko für kardiovaskuläre 
Mortalität in Beijing. Dabei waren die Auswirkungen für Erwachsene (≥ 15 Jahre) und 
ältere Einwohner  (≥ 65 Jahre) ähnlich. Die Auswirkungen von Hitze waren unmittelbar, 
während Kälte überwiegend mit längeren zeitlichen Verzögerungen wirkte. Die 
Assoziationen wurden nicht durch die Reihenfolge der drei Warmzeiten in der Studie, 
von Heizung im Winter, oder durch partikuläre Luftschadstoffbelastung modifiziert. 
          In den letzten Jahrzehnten konnte eine Assoziation zwischen Feinstaub und den 
kardiovaskuläre Erkrankungen gezeigt werden. Obwohl nur kleine Effekte beobachtet 
werden konnten, haben diese durch die Exposition der gesamten Bevölkerung eine 
große Auswirkung  auf die öffentliche Gesundheit. Die Expositions-Wirkungs- 
Funktionen zwischen kurzfristiger Exposition gegenüber Feinstaub und Mortalität oder 
Morbidität haben sich als nahezu linear erwiesen. Neben der chemischen 
Zusammensetzung wird auch die Partikelgröße als wichtige Messgröße diskutiert. 
Aufgrund der begrenzten Verfügbarkeit geeigneter Messdaten gibt es nur wenige 
epidemiologische Studien zu kurzfristigen Assoziationen zwischen täglicher 
kardiovaskulärer Mortalität oder Morbidität und größenspezifisch gemessenen Partikeln. 
          Wiederum in Beijing, China, wurden zwei Studien durchgeführt, um zu 
untersuchen, wie tägliche Veränderungen in größenspezifisch unterschiedlichen 
Partikeln mit kardiovaskulärer Mortalität und Notaufnahmen assoziiert sind. Dazu 
standen tägliche Anzahlen von kardiovaskulärer Mortalität, von Notaufnahmen 
aufgrund von kardiovaskulären Problemen, meteorologische Daten (potenzielle 
Confounders), sowie größenspezifisch gemessene Partikelmasse und –
anzahlkonzentration zur Verfügung. Die Auswirkungen von Partikeln unterschiedlicher 
Größe auf kardiovaskuläre Mortalität und Morbidität wurden mit  Poisson-
Regressionsmodellen geschätzt unter Verwendung von sogenannten „polynomial 
distributed lag“-Modellen. Dabei wurde ein erhöhtes Risiko für kardiovaskuläre 
Mortalität mit einer Verzögerung von zwei Tagen gefunden,  das durch erhöhte 
Anzahlkonzentrationen von Sub-Mikrometer-Partikeln induziert wurde. Es wurde auch 
eine verzögerte Assoziation zwischen kardiovaskuläre Notaufnahmen und erhöhten 
Anzahlkonzentrationen von ultrafeinen Partikeln gefunden, sowie ein erhöhtes Risiko 
am selben Tag, das durch Aitken-Modus und Akkumulationsmodus Partikeln induziert 
wurde.           
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3           Introduction 
 
3.1 Background 
 
3.1.1 Cardiovascular diseases 
              Cardiovascular disease (CVD) is now the number one cause of death globally 
[1]. Although the term “cardiovascular disease” refers to a class of diseases involving 
the heart, arteries and veins, it is usually a disease related to atherosclerosis. 
Atherosclerosis is a condition in which fatty material (e.g. cholesterol) accumulates on 
the wall of an artery, forms plaques and makes it narrow and hardened. The plaques or a 
thrombus formed by a sudden rupture of soft plaques could slow or stop blood flow, and 
result in ischemia or even necrosis of the tissues fed by the artery rapidly. If this 
happens in coronary arteries, it leads to atherosclerotic coronary heart diseases (CHD, 
e.g. angina pectoris, myocardial infarction), and in case it happens in arteries to the 
brain, it leads to a stroke. In 2004, an estimated 17.1 million people died from CVD 
worldwide, representing 29% of all global deaths; of these deaths, an estimated 7.2 
million were due to CHD and 5.7 million were due to stroke [1]. CVD are responsible 
for 10% of the disability-adjusted life years (DALYs) [2] lost in low- and middle-
income countries, and for 18% in high-income countries [3]. In 2006, costs directly and 
indirectly related to CVD were estimated to be 403.1 billion dollars in the United States 
[4]. In China, annual direct costs of CVD are estimated to be higher than 40 billion U.S. 
dollars, or roughly 4% of its gross national income [5]. 
 
3.1.2 Cardiovascular risk factors 
              The non-modifiable risk factors of CVD mainly include advancing age, gender, 
ethnicity, and heredity.  
              It was reported that for every 10-year increase in age, both men and women 
more than double their chances of dying due to CVD [6]. A prospective cohort study of 
men conducted in the United States showed that the incidence of new CVD continued to 
increase after the age of 80 [7]. The hypothesized reason is that the age-associated 
alterations in cardiovascular structure and function superimpose the specific 
pathophysiological mechanisms on the heart and vascular substrates causing clinical 
disorders in older individuals [8]. 
              In 1983, it was reported that the age-adjusted death rate for diseases of the heart 
among all males in the United States (260.4 per 100,000) was twice the rate for all 
females (132.3 per 100,000) [9]. Nowadays, researchers are aware that CVD affects 
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almost as many women as men [3], at least among elderly people, as after menopause, 
the risk for women increases sharply [6]. The reason of a narrowed difference between 
men and women could be that during the rapid industrialization and urbanization (e.g. in 
China), social, political, and economic factors have changed the lifestyle of women [10]. 
Risk factors for CVD in women are now generally the same as in men; some (e.g. 
tobacco use, high triglyceride level, [3]) are even more dangerous to women. Also, there 
was possible underestimation of the impact of CVD on women before. It may be 
attributed to the differences in symptomatology. Women experience more nausea and 
back pain during a heart attack, while men experience left arm pain and chest pain, 
which are thought to be the “classic” signs of a heart attack [11]. 
              In the United States, African-Americans have the highest age-adjusted CVD 
death rate, followed by Whites, Hispanics, and Asians [12]. In the United Kingdom, 
population of African or South Asian origin are at a particularly high risk of CVD [13]. 
And it is widely known that family history plays an important role on one’s possibility 
of encountering CVD [3]. 
              The major modifiable risk factors of CVD include hypertension, abnormal 
blood lipids, diabetes, obesity, and lifestyle-dependent factors such as physical inactivity, 
low fruit and vegetable diet, alcohol use and tobacco use. Other modifiable risk factors 
of CVD include low socioeconomic status (SES), mental illness, and use of certain 
medication. Environmental factors such as air pollution and temperature are also 
reported to promote CVD. 
              Hypertension (defined as a systolic blood pressure above 140 mmHg and/or a 
diastolic blood pressure above 90 mmHg) is one of the most important risk factors. 
Physical inactivity, obesity as well as low fruit and vegetable diet could all promote 
hypertension and future CVD; but for 90-95% of hypertension cases (termed “primary 
hypertension”) no medical cause can be found [14]. The risk of CVD doubles for every 
10 point increase in diastolic blood pressure or every 20 point increase in systolic blood 
pressure [3]. In the Canadian Cardiovascular Congress 2004 [15], Dagenais and 
colleagues presented that Quebec men aged 35 to 64 with a systolic blood pressure 
between 133 and 140 mmHg were almost twice as likely to have a heart attack or suffer 
from a sudden cardiac arrest than men whose systolic blood pressure was less than 125 
mmHg during a 23-year follow-up, showing that a blood pressure at the top end of the 
normal range still increases risk. China is a multi-ethnic nation; the prevalence and 
severity of hypertension are substantially different among ethnic groups [16, 17]. 
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              It is easily understood that higher total cholesterol level and triglyceride level in 
blood make patients more prone to atherosclerosis. Also the type of cholesterol plays a 
role: low-density lipoprotein (LDL), especially small dense LDL [18], is known to be an 
atherogenic lipoprotein. People having a total cholesterol level of 240 mg/dL or more, 
and a LDL level of 160 mg/dL or more are considered to be at high risk of CHD [19]. 
Kathiresan and colleagues [20] found that a genotype score of nine validated common 
single-nucleotide polymorphisms (SNPs) associated with modulation in levels of LDL 
or high-density lipoprotein (HDL) cholesterol was an independent risk factor for 
incident cardiovascular disease. 
              The World Diabetes Foundation [21] estimated that in 2010, 285 million people 
live with diabetes, corresponding to 6.4% of the world’s adult population. In China, an 
epidemic of diabetes has been announced; 92.4 million adults have diabetes (prevalence 
9.7%) and 148.2 million have pre-diabetes (prevalence 15.5%) [22]. The American 
Heart Association [21] considers that people with diabetes are two to four times more 
likely to develop CVD, including CHD, stroke, peripheral arterial disease and possibly 
cardiomyopathy. Insulin resistance, one of the underlying metabolic causes of type-2 
diabetes, is commonly accompanied by dyslipidemia, hypertension, and prothrombotic 
factors and could develop from obesity and physical inactivity, which are also major risk 
factors for CVD [23]. A 6-year prospective cohort study among 78,282 American 
women aged 54 to 79 years [24] showed that the age-adjusted relative risk (RR) of CVD 
mortality for women with diabetes was 2.67 (95% confidence interval (CI): 2.20-3.23). 
A cohort study of a relatively young (≥ 30 years) Middle East population [25] showed 
that CHD patients with diabetes had a worse prognosis than those without diabetes. 
              Obesity has become a global epidemic in both adults and children. In the 
United States, 60% of all adults are currently either obese or overweight [26]; the WHO 
estimated that by the end of 2010 there are 43 million overweight and obese children 
under 5 years of age worldwide and 75% of them come from low- and middle-income 
countries [27]. The Body Mass Index (BMI, body weight (kg) divided by the square of 
height (m2)) is commonly used for classifying overweight or obesity. Recent pooled 
analyses of more than 1.1 million people recruited in 19 cohorts in Asia [28] found a U-
shaped association between BMI and the risks of death from CVD. A study [29] showed 
that a high BMI was associated with lower mortality in elderly heart failure patients 
when compared with normal weight ones (“obesity paradox”), suggesting that for the 
elderly parameters such as measures of body composition, fat, and fat-free mass may be 
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of greater importance than BMI. 
              Sedentary lifestyle and fast food increase people’s risks of high blood pressure, 
diabetes, overweight or obesity, and high triglycerides, which are all risk factors of CVD. 
It has been suggested that in China urbanization associated adverse changes in diet and 
physical activity level might be a reason for the increasing burdens of hypertension, 
diabetes and high cholesterol level [30]. According to the WHO, worldwide physical 
inactivity is estimated to cause 20% of CVD and 22% of CHD; low fruit and vegetable 
intake is estimated to cause 31% of ischemic heart disease and 11% of stroke. 
              Moderate alcohol consumption has been associated with a lower risk of CHD in 
healthy people, partly explained by its beneficial effects of raising high-density 
lipoprotein (HDL) and anti-clotting [31]. Although any type of alcoholic beverage 
appears beneficial, red wine seems to confer additional health benefits because of the 
presence of red wine polyphenolic compounds (RWPC) [32]. RWPC are antioxidants 
which could lower free radical properties, the aggregation of platelet and the thrombotic 
activities; they are also powerful vasodilators, contribute to the preservation of the 
integrity of the endothelium and the inhibition of smooth muscle cell proliferation and 
migration [32]. However, the American Heart Association [19] recommends people who 
do not drink never to start, as many other ways such as controlling body weight, regular 
physical activities, and a healthy diet could decrease the risk of CVD, and bring no 
potential risk of drinking too much or even alcoholism. Too much alcohol intake will 
increase blood pressure and triglycerides, and elevate the risk for obesity because of the 
extra calorie intake. 
              The inverse association between SES and CVD risk in high-income countries is 
the result of low-income population’s life style and behaviour patterns (e.g. higher 
prevalence of smoking), psychosocial stress caused by chronic life stress, social 
isolation and anxiety, and less ease of access to health care [33, 3]. Two papers from 
Canada showed that educational achievement represented SES best [34, 35]. CVD was 
reported to be associated with both anxiety disorder and mood disorder [36]. 
Epidemiological studies have consistently shown excess CVD mortality in patients with 
schizophrenia, bipolar disorder and depression. The excess cardiovascular mortality 
associated with schizophrenia and bipolar disorder is attributed in part to an increased 
risk of the modifiable coronary heart disease risk factors e.g. obesity, smoking, diabetes, 
hypertension and dyslipidaemia [37]. Drug-induced hypertension, cerebrovascular 
diseases and heart failure have been discussed. A history of elevated blood pressure is a 
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major risk factor for drug-induced hypertension [38]. Several classes of drugs may 
precipitate the occurrence of heart failure in patients with pre-existing left ventricular 
impairment [39]. 
              There has been a huge amount of scientific literature showing an association 
between smoking (cigarette or other forms) or passive smoking and CVD. Smoking has 
been estimated to cause about 11% of all deaths due to CVD [40]. The risk of 
developing an acute cardiac syndrome or chronic lifetime coronary events after second-
hand smoke exposure is at least 30% [41]. Research about mechanisms has shown that 
cigarette smoking could induce vascular oxidative stress, increase oxidative DNA 
damage in endothelial cells, induce vascular inflammation, and activate the production 
of circulating monocytes and their adhesion to the endothelium [42]. Reactive oxygen 
species and the activation of inflammatory pathways play a central role in the 
accelerated cardiovascular aging in smokers [42]. In 2001, Humphries and colleagues 
[43] suggested that smoking is a risk factor for CHD, particularly in men carrying the 
Apo-lipoprotein E4 allele. This may explain why some smokers get heart diseases while 
others get e.g. lung or bronchial problems. 
              Over the last decade, ambient air pollution has increasingly been linked with 
CVD [44]. Recent studies have reported associations of short-term exposure to 
particularly traffic-related air pollution on adverse outcomes including stroke [45], 
myocardial infarction [46-48] and disturbances of the autonomic control of the heart 
[49]. Epidemiological studies have demonstrated a consistent increased risk for 
cardiovascular events in relation to exposure to present-day concentrations of ambient 
particulate matter (PM) [44]. For more details about the effects of PM on CVD, please 
see chapter 3.1.3. 
              CVD has also been linked with short-term air temperature fluctuation, not only 
extreme temperature events known as heat waves or cold spells, but also increases or 
decreases in moderate temperature. For more details about the effects of air temperature 
variation on CVD, please see chapter 3.1.4. 
  
3.1.3 Particulate air pollution and cardiovascular health 
              Ambient PM has increasingly been linked with CVD during the last decades 
[44]. Different size fractions of PM are under investigation: PM with an aerodynamic 
diameter smaller than 10µm (PM10) or 2.5µm (PM2.5 or fine particles), PM with 
diameters between 2.5µm and 10µm (coarse particles), as well as particles smaller than 
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100nm (ultrafine particles, UFP) [44]. As a risk factor, air pollution needs to be 
considered differently than traditional cardiovascular risk factors. Traditional risk 
factors (e.g. smoking, obesity, race etc.) exert their influences on a limited proportion of 
population, although in some cases demonstrating large relative risk. Air pollution is a 
continuous exposure affecting the whole population; although the relative risk could be 
small, it still has a large public health impact [50]. 
              PM10, PM2.5 and coarse particles are typically measured in their mass per 
volume of air (µg/m3), whereas UFP are most often measured by their number (per cm³) 
[51]. They have different sources, potential distances of being transported in air, and 
locations of deposition in human lungs. PM2.5 and UFP are of more importance for 
urban population, as they are predominantly emitted from combustion processes of 
fossil fuels (high carbon content), e.g. from industry, traffic, power generation 
(especially diesel engines for UFP). While both PM2.5 and UFP can penetrate deep into 
lungs reaching the alveoli, only UFP are possibly crossing over into the bloodstream. 
[50] 
              The shape of the exposure-response functions between short-term exposure to 
PM and cardiovascular mortality and morbidity is considered to be near-linear and 
without a threshold [52]. Except for CVD mortality and hospital admissions (morbidity), 
effects on the cardiovascular system observed for short-term fluctuations of ambient PM 
also include ischemia and arrhythmia in patients with coronary artery disease, altered 
heart rate and autonomic control, altered blood pressure, systemic inflammatory 
response, pro-thrombotic state and endothelial dysfunction [53]. 
              The correlations between fine and coarse particles are typically found to be 
around or somewhat lower than 0.5 [54]. Both subcategories of PM10 (coarse and fine 
particles) showed short-term effects on cardiovascular mortality or admission, but the 
significance and magnitude of the effects estimate were inconsistent [54]. So it is hard to 
determine which one contributes more to the effects of PM10, although several studies 
showed that the effects of coarse particles on short-term total mortality no longer existed 
after adjusting for fine particles in a two-pollutant analysis [54]. UFP are supposed to be 
a great contributor to the observed cardiovascular effects of PM2.5, mainly due to the 
large active surface area and high deposition efficiency in the pulmonary region [55, 
56]. 
              With regard to the potential mechanisms through which exposure to PM leads 
to CVD, there are three main pathways proposed: a) activation of pulmonary receptors 
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resulting in autonomic nervous system imbalance and the development of dysrhythmias; 
b) induction of pulmonary and systemic inflammation; c) access of particles or chemical 
constituents to the systemic circulation [57]. 
              After establishing the associations between PM and CVD, researchers were 
interested in finding out the constituents of PM which are responsible for their 
observations. High fractions of nickel, vanadium, selenium and elemental carbon (EC) 
were reported to increase the risks of PM2.5-related CVD mortality and hospitalization 
[58-60]. Urban UFP contain greater relative amounts of polycyclic aromatic 
hydrocarbons (PAH) than the bigger fine and coarse particles, which could be one of the 
reasons that explain UFP’s greater redox potential [57]. Coarse particles contain more 
crustal materials (e.g. silicon, calcium) due to their sources (mechanical grinding, 
windblown dust, and agricultural activities) [61]. However, the concentrations of 
particles within the coarse size range in urban environments generally are more 
influenced by transportation than in rural environments [62]. 
              Due to the limited availability of appropriate measurement data, there are only 
few epidemiological studies on the short-term associations between daily cardiovascular 
mortality and more accurately size-segregated particles [63-67]. Nearly all studies on 
health effects of smaller particles have been conducted in North America and Europe; 
however, concentration levels in China are very different and there might also be 
differences in specific sources and particle composition and their proportional 
contributions to the air pollution mixture which might influence the associations 
between human health and air pollution.  
 
3.1.4 Air temperature and cardiovascular health 
              CVD has been linked to climate fluctuation, although uncertainty remains in 
attributing the expansion of CVD to it, due to the lack of long-term, high-quality 
datasets as well as the large influence of socio-economic factors and changes in 
population characters. The Intergovernmental Panel on Climate Change (IPCC) has 
recommended short-term air temperature fluctuations as a first step for analyzing the 
association between climate fluctuation and mortality or morbidity [68]. 
              Heat waves but also moderately elevated temperatures contribute to the 
observed heat-related cardiovascular mortality [69-73]. Different lag times have been 
reported for the association of heat with cardiovascular mortality; however all lag times 
were rather immediate, ranging from the same day to three days following a temperature 
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increase [72-77]. The exposure-response functions between mortality time-series and 
continuous temperature measures have been shown to be U- or J-shaped, and the range 
of temperatures corresponding with a minimum mortality (“threshold”, “turning point” 
or “optimum temperature”) was reported to be related with latitude, so that the residents 
of lower latitudes tended to be susceptible only at higher temperature values, indicating 
a reduced susceptibility to heat [72, 76-78]. 
              Although the short-term effects of high air temperatures on cardiovascular 
mortality have been well documented, there is much less evidence about the effects of 
high temperature on morbidity [79]. Several studies on heat waves as well as normal hot 
weather showed increases in hospital admission for CVD [80-82]. But some other 
studies showed inconsistent results with negative or no associations between high 
temperatures and cardiovascular or cerebrovascular hospital admissions [79, 83]. The 
impact of hot weather on mortality being not paralleled by similar magnitude increases 
in hospital admissions supports the hypothesis that many heat-related deaths occur in 
people before they come to medical attention [83]. 
              Excess winter mortality has been well known [84, 85]. Cold spells have been 
reported to be related to excess mortality mostly attributable to CVD and, in particular, 
to elderly people [86]. Low temperatures usually showed delayed effects on 
cardiovascular mortality, from four to 20 days [74, 87-89]. The exposure-response 
functions between mortality and multiple-day moving averages of temperature were 
reported to be negative linear [59, 90]. However, the relationship between cold and 
cardiovascular mortality is not consistent. A study in Yakutsk, Eastern Siberia, where 
temperature fell even to -48.2°C, found no effect of decreased temperature on ischemic 
disease mortality, possibly indicating population adaptation to local climate [91]. 
              Exposure to cold is of course also thought to influence cardiovascular 
morbidity. Studies have shown negative linear correlations between air temperature and 
the occurrence of myocardial infarctions (MI) and coronary events [92, 93], significant 
increments of hospitalization due to heart failure in winter compared to summer [94], 
inverse correlations between temperature and cerebrovascular admission [95, 96] as well 
as an increase in blood pressure elicited by superficial skin cooling [97]. Some studies 
were able to separate subgroups and found e.g. stronger cold effects on recurrent MI and 
coronary events compared with the first attack [92], as well as more excess winter 
events of intracerebral hemorrhage than subarachnoid hemorrhage and ischemic stroke 
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[98]. However, protective effects of low temperatures on heart diseases were also 
reported [99]. 
              High or low air temperature may not really elevate the cardiovascular mortality 
of a population, but only cause a short-term forward shift in mortality, meaning that the 
vulnerable people (e.g. elderly people, people with existed chronic diseases) died a few 
weeks earlier before the time point at which they might die if air temperature hadn’t 
changed. This is referred to as “mortality displacement” [100]. In this case, a decrease in 
mortality during the subsequent weeks after the high or low temperature period could be 
observed. 
              Possible mechanisms through which elevated temperature increases CVD 
include enlarged skin vessels and facilitated sweat, leading to falling blood pressure, 
increased cardiac work load and loss of fluid and salt, further leading to 
haemoconcentration, a “thrombosis promoting” state. The activation of coagulation and 
inhibition of fibrinolysis lead to diffuse microvascular thrombosis. Besides, heat-
induced release of interleukin (IL)-1 or IL-6 into systemic circulation results in damage 
and hyperactivation of endothelial cells. [67] Possible mechanisms through which low 
temperature increases CVD include the stimulation of cold receptors in the skin, 
followed by an upward regulation of the catecholamine level by the sympathetic nervous 
system and a constriction of the skin vessels to reduce heat loss. Blood pressure 
increases consequently, and approximately 1L of blood plasma is shifted from skin and 
legs to central body parts, then removed by urine or shifted to extra-cellular space. The 
shift of blood plasma leads to haemoconcentration, leading to an increase of the 
concentrations of red and white blood cells, platelets, certain clotting factors, cholesterol 
and fibrinogen, as well as blood viscosity, which promotes clotting and thrombosis. 
Moreover, protein C, which is an anticoagulant, moves out to the extra-cellular space 
with blood plasma. The rise of blood pressure may lead to oxygen deficiency in the 
cardiac muscle which might induce myocardial ischemia or arrhythmias. If the rise of 
blood pressure is too sudden, there is the possibility of vascular spasm and a rupture of 
an atherosclerotic plaque that induces a thrombus [101-106]. 
              Until today, most studies regarding weather and climate effects on health have 
been conducted in Europe and the United States; however, there is a lack of data and 
publications about the temperature-mortality relationship in the Asian region. 
 
3.2 Specific aims 
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1) To investigate the association between daily air temperature and daily 
cardiovascular mortality in the urban area of Beijing, China. Moreover, to check which 
age-group (adult or elderly residents) is affected more by heat or cold in this area, and if 
air pollution plays a confounding or inter-acting role in the temperature-mortality 
relationship. 
2) To investigate whether daily changes in ambient concentrations of particle size 
fractions in the sub-micrometer range are associated with cause-specific cardiovascular 
mortality in different age groups in Beijing, China. Moreover, to better delineate 
whether particle number, mass, or surface area concentrations may be responsible for 
the associations, and whether there is a modification of the air pollution effects by air 
mass origin defined by backward trajectories. 
3) To investigate whether daily changes in ambient concentrations of particle size 
fractions in the range of 3nm to 10µm are associated with cardiovascular emergency 
room visits in Beijing, China. Moreover, to better delineate whether using particle 
number or mass concentration may affect the associations. 
 
3.3 Results 
 
3.3.1 Air temperature and cardiovascular health [107] 
              In the first publication (see chapter 4), I conducted a study aiming at 
investigating the association between daily air temperature and daily cardiovascular 
mortality in the urban area of Beijing, China. Moreover, I was interested in the age-
group (adult or elderly residents) that is affected more by heat or cold in this area and 
investigated in addition, if air pollution plays a confounding or inter-acting role in the 
temperature-mortality relationship. 
              I conducted the study in the urban area of Beijing, China, from 1 Jan 2003 to 31 
Aug 2005 (1,368 km2, approximately 7,072,000 registered permanent residents, 974 
days). I obtained daily death counts due to CVD as well as two subcategories - ischemic 
heart diseases and cerebrovascular diseases - for adult residents (≥ 15 years) and elderly 
residents (≥ 65 years). I further obtained daily mean temperature, relative humidity, and 
barometric pressure as well as daily concentrations of ambient particulate matter with an 
aerodynamic diameter < 2.5 µm (PM2.5) and < 0.1 µm (ultrafine particles, UFP). I 
estimated the effects of two-day and 15-day average temperatures on mortality by 
Poisson regression controlling for potential confounders, for warm (April to September) 
and cold periods (October to March) separately. 
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              All the exposure-response functions between two-day or 15-day average 
temperature and cardiovascular, ischemic or cerebrovascular mortality showed no 
obvious U- or J-shape and could be considered linear. The relative risks (RR, with 95% 
confidence intervals, 95% CI) per 5°C increase of two-day average temperature in the 
warm period (representing heat effects) associated with cardiovascular, ischemic and 
cerebrovascular mortality were 1.098 (1.057, 1.140), 1.020 (0.975, 1.067) and 1.047 
(1.000, 1.097), respectively, for the adult residents; the RRs for elderly residents were 
similar, only the one associated with cerebrovascular mortality was a bit higher with 
1.064 (1.008, 1.123). The RRs (95% CI) per 5°C decrease of 15-day average 
temperature in the cold period (representing cold effects) associated with cardiovascular, 
ischemic and cerebrovascular mortality were 1.057 (1.022, 1.094), 1.123 (1.057, 1.193) 
and 1.036 (1.002, 1.071), respectively, for the adult residents; the RRs for elderly 
residents were of similar magnitudes. 
              The order of the three different warm periods within the whole study period 
(April to September in 2003: 1st warm period, April to September in 2004: 2nd one, and 
April to August in 2005: 3rd one) showed no significant interaction with two-day 
average temperature, and therefore indicates that there was no heat effect modification 
by potential population adaptation to heat or by possible increasing prevalence of air-
conditioning year by year. I also found no interaction between heating and 15-day 
average temperature after an analysis within the cold period, showing that residential 
heating didn’t modify the cold effect. This might also reflect that the study population 
exposed themselves to outdoor temperature although they probably spent a lot of time 
indoors. When considering for confounding by PM2.5 or UFP with a lag of two days as 
the most relevant air pollution lag [108], there were no relevant changes for two-day 
average temperature effects, and a drop in 15-day average temperature effects on 
cardiovascular mortality. For more details please see the publication in chapter 4. 
              In the publication in chapter 4 I additionally estimated the effects of two-day 
and 15-day average temperatures on respiratory mortality. Elevated air temperature 
showed effects on respiratory mortality in both warm and cold periods. The effect in 
warm periods was higher than the one on cardiovascular mortality. The effects were also 
not modified by the order of the three warm periods or the residential heating in cold 
periods. Furthermore, the effects did not change after considering lag 2 PM2.5 or UFP as 
confounders. 
 
16
3.3.2 Particulate air pollution and cardiovascular health [108, 109] 
              Moreover, I conducted two studies aiming at investigating how daily changes in 
ambient concentrations of size-segregated particles in Beijing, China were associated 
with cardiovascular mortality and emergency room visits, respectively. Moreover, I 
aimed to better delineate whether different types of particle concentrations used may be 
responsible for the associations. In addition, in the study regarding cardiovascular 
mortality, I investigated which age-group (adult or elderly residents) is affected more 
and whether air mass origin modifies the air pollution effect. 
              The study investigating particulate effect on cardiovascular morality (see 
second publication in chapter 5) was conducted in the urban area of Beijing, from March 
2004 to August 2005 (1,368 km2, approximately 7,072,000 registered permanent 
residents, 546 days). I obtained daily cardiovascular death counts as well as two 
subcategories - ischemic diseases and stroke - for adult residents (≥ 15 years) and 
elderly residents (≥ 65 years). I also obtained continuously measured particle size-
distribution data of particles with a size up to 0.8 µm as well as meteorological and air 
mass history data. The size-distribution data were converted to particle number, mass, 
and surface area concentrations (NC, MC and SC, respectively) assuming spherical 
particles. For this study, I used daily mean NC of Nucleation mode (0.003-0.03 µm) and 
Aitken mode (0.03-0.1 µm) particles, daily mean MC and SC of two subgroups (0.1-0.3 
µm, 0.3-0.8 µm) of accumulation mode particles (ACP, 0.1-0.8 µm), and daily mean 
NC, MC and SC of particles in the range from 0.003 to 0.8 µm (NC1, PM1 and SC1). I 
estimated the effects of particle metrics on cardiovascular mortality for single-day lags 
from 0-3 days and the average of days 0-4 (5-day mean) by Poisson regression 
controlling for potential confounders.  
              I could see associations between daily cardiovascular mortality and particle NC 
in the Aitken mode range as well as NC1. The strongest associations were found for a 
delay of two days; the RRs (95%CI) were 4.04 (1.18, 6.98) for lag 2 NC of Aitken mode 
particles and 4.92 (1.50, 8.45) for lag 2 NC1, respectively. These 2-days-delayed 
associations were not confounded by any other particle metrics. When ischemic 
mortality was analyzed separately, I found a consistent two-days-delayed association 
with all particle metrics except with NC of Nucleation mode particles. But the 
associations between ischemic mortality and MC/SC of ACPs as well as PM1/SC1 
diminished, when adding lag 2 NC of Aitken mode particles in the models. Associations 
between particle metrics and cardiovascular mortality for elderly people showed similar 
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effects compared to the results found for the adult population. Associations between 
cardiovascular and ischemic mortality and particle NC in the Aitken mode range and 
NC1 were not modified by air mass origin. Although not statistically significant, results 
indicated that mortality effects of SC and MC with a lag of two days were stronger for 
stagnant and southern air masses compared to air masses arriving from northerly 
directions with average to high wind speed. An increase of 973.7 µm2/cm3 in SC1 
resulted in a 6.6% increase (95% CI: 1.78, 11.55) in ischemic mortality for stagnant and 
southern air masses compared to a 2.9% increase (-1.20, 7.25) for air masses from 
northerly directions with average to high wind speed. An increase of 81.8 µg/m3 in PM1 
resulted in a mortality increase of 5.9% (1.42, 10.64) for stagnant and southern air 
masses, compared to 2.4% (-1.66, 6.59). For more details please see publication in 
chapter 5. 
              The study investigating particulate effects on cardiovascular emergency room 
visits (see third publication in chapter 6) was conducted in Beijing (urban and suburban 
areas), from March 2004 to December 2006 (16,411 km2, approximately 15,380,000 
registered permanent residents, 1033 days). I obtained total cardiovascular as well as 
severe cardiovascular emergency room visit count data (a combination of ischemic heart 
diseases, arrhythmia, heart failure and cerebrovascular diseases) (referred as ERVT and 
ERV, respectively), continuously measured aerosol number size distribution data of 
particles with a size range of 3 nm to 10 µm as well as meteorological data. The size 
distribution data were converted to particle number and mass concentrations (NC and 
MC) assuming spherical particles. I estimated the cumulative lagged effects of particles 
within different size ranges on ERVT and ERV up to 15 days using polynomial 
distributed lag (PDL) models. I then quantitatively estimated the effects of 8-day 
moving average (MA) of particle NC and MC of lags 0-7 and explored the exposure-
response functions between the 8-day MA of particle NC or MC and ERVT or ERV by 
Generalized additive models (GAM) controlling for potential confounders. Both PDL 
models and GAM are Poisson regression models.  
              The main results of this study were the four to ten-days delayed effects of NC 
of UFP on ERVT and ERV, as well as the current-day effects of NC of Aitken mode 
(the latter two size fractions within UFP range) and accumulation mode (100-300 nm 
and 300-1000 nm) particles on both outcomes. I could also see significant current-day 
effects of NC of PM1. Those effects were dominated by the two size fractions 10-30 nm 
and 30-50 nm. The IQR of lag 0-7 moving average NC of UFP, PM1, 10-30 nm particles 
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and 30-50 nm particles were 9450cm-3, 11270cm-3, 3248cm-3 and 2076cm-3, respectively. 
The RRs (95%CIs) of ERVT associated with per IQR increases then, respectively, were 
1.12 (1.05, 1.19), 1.11 (1.04, 1.19), 1.13 (1.06, 1.20) and 1.09 (1.03, 1.15). The RRs 
(95%CIs) of ERV were 1.10 (1.03, 1.18), 1.10 (1.02, 1.19), 1.10 (1.02, 1.18) and 1.07 
(1.00, 1.14). Looking at the fragment with most of the NC or MC data of each exposure-
response function plot, only the function associated with the 8-day MA of NC of 3-10 
nm particles seemed to show a J-shape; the other functions did not substantially deviate 
from linearity. The PDL curves for the effects of NC and MC of 100-300 nm and 300-
1000 nm particles on ERVT or ERV were quite similar, indicating that particle metrics 
do not seem to affect the effects of particles in this size range. With regard to each size 
fraction, the effect of particles on ERVT was in most cases higher than the effect on 
ERV, except for the NC of 3-10 nm particles. 
 
3.4 Discussion and conclusions 
 
1) Both increases and decreases in air temperature are associated with an 
increased risk of cardiovascular mortality in Beijing. The effects of heat were immediate 
while the ones of cold became predominant with longer time lags. These findings are in 
agreement with the findings of studies conducted in Europe and the United States. The 
heat effect I found is smaller then what Chung et al. [72] found in Beijing, but is 
comparable to what Almeida et al. [73] found in Lisbon, a city with similar latitude as 
Beijing. The cold effect I found is smaller then what Analitis et al. [89] found in Europe. 
In our study, the temperature effects on adult (≥15 years) and elderly (≥65 years) 
residents were similar. And the associations were not confounded or modified by 
ambient particulate air pollution. 
2) There is an elevated risk of cardiovascular mortality or ischemic mortality 
(when analyzed separately) in Beijing from short-term exposure to particulate air 
pollution in the sub-micrometer range. The observed effects of the number concentration 
(NC) of particles are not confounded by other particle metrics; while the observed 
effects of the mass (MC) or surface area concentrations (SC) of particles diminished 
when adding the NC in the models. The associations between particle metrics and 
cardiovascular mortality for elderly people were similar compared to the results found 
for the adult population. Associations between cardiovascular and ischemic mortality 
and the sub-micron particles were not substantially modified by air mass origin. The 
pronounced effect of NC of sub-micron particles I found is in agreement with other 
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previous studies [63, 66, 110-112].  
3) The analyses showed an elevated risk of cardiovascular emergency room visits 
in Beijing associated with short-term exposure to particulate air pollution. In particular, 
delayed effects of NC of UFP and immediate effects of NC of Aitken mode and 
accumulation mode particles were observed. If compared with the results from other 
studies [63, 66, 67, 108], my observed UFP effect on cardiovascular emergency room 
visits was more delayed. But my observed immediate effects of sub-micron particles 
were comparable to what Branis et al. [64] reported in their study of cardiovascular 
hospital admissions in Prague. 
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Associations between air temperature and cardio-
respiratory mortality in the urban area of Beijing,
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Abstract
Background: Associations between air temperature and mortality have been consistently observed in Europe and
the United States; however, there is a lack of studies for Asian countries. Our study investigated the association
between air temperature and cardio-respiratory mortality in the urban area of Beijing, China.
Methods: Death counts for cardiovascular and respiratory diseases for adult residents (≥15 years), meteorological
parameters and concentrations of particulate air pollution were obtained from January 2003 to August 2005. The
effects of two-day and 15-day average temperatures were estimated by Poisson regression models, controlling for
time trend, relative humidity and other confounders if necessary. Effects were explored for warm (April to
September) and cold periods (October to March) separately. The lagged effects of daily temperature were
investigated by polynomial distributed lag (PDL) models.
Results: We observed a J-shaped exposure-response function only for 15-day average temperature and respiratory
mortality in the warm period, with 21.3°C as the threshold temperature. All other exposure-response functions
could be considered as linear. In the warm period, a 5°C increase of two-day average temperature was associated
with a RR of 1.098 (95% confidence interval (95%CI): 1.057-1.140) for cardiovascular and 1.134 (95%CI: 1.050-1.224)
for respiratory mortality; a 5°C decrease of 15-day average temperature was associated with a RR of 1.040 (95%CI:
0.990-1.093) for cardiovascular mortality. In the cold period, a 5°C increase of two-day average temperature was
associated with a RR of 1.149 (95%CI: 1.078-1.224) for respiratory mortality; a 5°C decrease of 15-day average
temperature was associated with a RR of 1.057 (95%CI: 1.022-1.094) for cardiovascular mortality. The effects
remained robust after considering particles as additional confounders.
Conclusions: Both increases and decreases in air temperature are associated with an increased risk of cardiovascular
mortality. The effects of heat were immediate while the ones of cold became predominant with longer time lags.
Increases in air temperature are also associated with an immediate increased risk of respiratory mortality.
Background
In recent years, concern on the effects of meteorological
factors on population health has increased. Research
started by exploring the effects of weather, since its rela-
tionship with certain health outcomes is relatively easy
to be investigated compared to rather long-term climate
changes. The Intergovernmental Panel on Climate
Change (IPCC) has recommended short-term air tem-
perature fluctuations as one of the main markers for
analyzing the association between climate and mortality
or morbidity [1].
So far, the association between air temperature and
mortality has been investigated in various locations of the
world, either by simple descriptive statistics or by time-
series or case-crossover approaches. Results obtained from
heat wave events formed most of the existing evidence
of heat effects on mortality from 1970s until today [2].
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The 2003 European heat wave and 2006 California heat
wave are two prominent recent events. Excess deaths in
early August 2003 were speculated to be at least 33,120
for Western Europe [3] (maximum “% excess death”
was found to be 60% for France from 1 to 20 August, 2003
[4]); while 655 (6%) excess deaths were estimated for Cali-
fornia from 15 July to 1 August, 2006 [5]. However, not
only heat waves but also increases in moderate tempera-
ture contribute to the observed heat-related mortality.
Exposure-response functions between mortality time-ser-
ies and continuous temperature measures have shown V-,
U- or J-shaped associations, and the range of temperature
corresponding with a minimum mortality (“threshold”,
“turning point” or “optimum temperature”) was reported
to be related with latitude [6,7]. The residents of lower
latitudes tended to be more vulnerable only at higher tem-
perature values, indicating less susceptibility to heat [8-10].
Excess winter mortality has been well known (which
may have also caused that in recent years, particularly in
the light of global warming, there were fewer studies
particularly focusing on cold spells or temperature
decreases). The Eurowinter study [11] found that annual
excess deaths due to cold ranged from 408 to 1,617 for
eight European regions on days colder than 18°C.
Barnett et al. [12] compared coronary events occurring
in the coldest 25% of periods with those occurring in
the rest of periods among the WHO MONICA project
population and found an overall increase. In a recent
large multi-centre European study (PHEWE, 15 cities),
Analitis et al. [13] found that a 1°C decrease in 16-day-
average minimum apparent temperature was associated
with 1.25%-3.30% increases of total or cause-specific
mortalities.
Until today, most studies regarding weather and cli-
mate effects on health have been conducted in Europe
and the United States; however, there is a lack of data
and publications about the temperature-mortality rela-
tionship in the Asian region. For this reason, we con-
ducted the present study aiming at investigating the
association between daily air temperature and daily car-
diovascular as well as respiratory mortality in the urban
area of Beijing, China. Moreover, we were interested in
the age-group that is affected the most by heat or cold
in this area and investigated in addition, if air pollution
plays a role in the temperature-mortality relationship.
Material and methods
Study area and period
We conducted the study in the urban area of Beijing,
China, from 1 Jan 2003 to 31 Aug 2005 (974 days). Beij-
ing is located on the North China Plain surrounded by
mountains of 1000-1500 m in altitude to the west,
north, and northeast, while Bohai Sea on the southeast
side. Typical warm temperate semi-humid continental
monsoon climate brings Beijing hot, humid summers
and cold, dry winters. Springs and autumns are both
of relatively short duration. The urban area of Beijing
is about 1,368 km2 consisting of eight districts (see
Figure 1) with approximately 7,072,000 registered per-
manent residents [14].
Mortality data
We obtained mortality data in the Beijing urban area for
adult residents (≥ 15 years) from Beijing Centers for Dis-
eases Control and Prevention (CDC). We calculated daily
death counts for adults (referring as “the whole popula-
tion”) as well as for individuals of 65 years and older.
Daily death counts included deaths due to cardiovascular
(ICD-10 code: I00-I99), respiratory (J00-J99), and cardi-
orespiratory (I00-J99) diseases. We further considered
death counts for ischemic heart diseases (I20-I25) and
cerebrovascular diseases (I60-I69), which were the two
major cardiovascular subcategories. Influenza and pneu-
monia (J10-J18) and chronic lower respiratory diseases
(J40-J47), the two major respiratory subcategories, were
not analyzed because of too small counts.
Meteorological and air pollution data
Daily meteorological data were available from China
Meteorological Data Sharing Service System (station
54511, located at N39°48’ E116°28’ in the south eastern
part of Beijing within Daxing District, see Figure 1) and
included daily mean temperature, relative humidity, and
barometric pressure. We further calculated apparent
temperature (a measure of individually perceived dis-
comfort due to a combination of temperature and
humidity) [15]. Daily mean meteorological data from
another measurement station (Houhai, located in the
centre of Beijing, see Figure 1) was gathered from an
internet weather service (Weather Underground 2011)
as well, but contained missing values. The Pearson cor-
relation coefficients for valid days between the two data
sources were 0.995, 0.967 and 0.999 for daily air tem-
perature, relative humidity and barometric pressure,
respectively, indicating a good agreement.
Daily mass concentrations of ambient particulate matter
with an aerodynamic diameter <2.5 μm (PM2.5) and num-
ber concentrations of ambient particles with an aerody-
namic diameter <0.1 μm (ultrafine particles, UFP) were
obtained from a joint cooperation between Peking Univer-
sity, Beijing, China, and Leibniz-Institute for Tropospheric
Research, Leipzig, Germany [16]. The measurement sta-
tion for aerosol size distribution data is located on Peking
University campus area in the north western part of Beij-
ing (see Figure 1). The number size distribution was used
to calculate number concentrations of UFP, and mass con-
centrations of PM2.5 assuming spherical particles with a
mean particle density of 1.5 g cm-3. Details are described
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elsewhere [17]. Particle data were available only from
March 2004 on.
Statistical analyses
We used generalized semi-parametric Poisson regression
to model the natural logarithm of the expected daily
death counts as a function of the predictor variables.
Penalized splines were used to allow for non-linear con-
founding and temperature effects. Data were analyzed
using the package “mgcv” version 1.4-1.1 in the statisti-
cal software R version 2.7.2 (R Development Core
Team, 2008).
We explored the effects of air temperature on mortal-
ity within warm period (April to September) and cold
period (October to March) separately.
In a first step, a base model was built without air tem-
perature exposure for each category of mortality individu-
ally (see Additional file 1, Table S1). To control systematic
variations over time, we considered long-term trend as
well as dummy variables for season, day of the week
(DOW), and public holidays as potential confounders. As
potential meteorological confounders we considered daily
mean relative humidity and barometric pressure with the
same type of lag as the temperature term. To ensure suffi-
cient adjustment for season and other meteorological
parameters, time trend and relative humidity were forced
into all models. Season, day of the week, public holidays
and barometric pressure were only included if they
improved model fit. As a criterion to guide the selection of
degrees of freedom (DF) for trend, we used the minimiza-
tion of the absolute value of the sum of the partial auto-
correlation function (PACF) of the model’s residuals for a
fixed number of lags [18]. Model selection for the other
confounders was carried out by minimizing the General-
ized Cross Validation (GCV) criterion [19].
We considered the mean of lags 0 to 1 and of lags 0 to
14 for air temperature exposure. The focus on these
averages was chosen on the basis of previous studies con-
ducted in Europe, Northern America, and other places
around the world [13,20-22]. Firstly, we added them to
the base models and estimated the exposure-response
functions for temperature effects using penalized splines
Figure 1 Beijing and the urban area of Beijing (shaded).
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with four knots. Then, if the function was linear or
almost linear, temperature effects were directly presented
as relative risk (RR) of death per 5°C increase if positive
linear or decrease if negative linear, respectively. If the
function was non-linear, we selected a temperature
breakpoint (which we commonly call “threshold”) by
minimizing the Akaike Information Criterion (AIC) for a
range of different threshold values. Then for a J-shaped
function, only the temperatures above the threshold were
used for effect estimation. In this case, temperature
effects were presented as relative risk (RR) of death per
5°C increase in temperature above the threshold.
After having explored the effects of air temperature on
mortality for the whole population as described above,
we repeated the same procedure for mortality of elderly
people (65 years and above) only.
Furthermore, we applied polynomial distributed lag
(PDL) models [23] to avoid problems related to co-linear-
ity among lagged exposure variables. We investigated the
lagged effects of air temperature up to 29 days on the
whole population as well as the elderly people (65 years
and above), for warm period and cold period. We con-
strained the shape of the distributed lag curve to follow a
polynomial of 5th-order in order to get a flexible func-
tional form.
Sensitivity analyses
We used different threshold temperatures for a J-shaped
function for the whole population and the elderly people.
All other sensitivity analyses were done only for the whole
population. Sensitivity analyses included the use of differ-
ent values of smoothness for the functions of time trend.
We also estimated the exposure-response functions using
apparent temperature instead of mean air temperature,
again considering two-day and 15-day averages. Moreover,
we re-analyzed the air temperature effects on mortality for
the shorter warm (April to September 2004 plus April to
August 2005) or cold (March 2004 plus October 2004 to
March 2005) period, during which the ambient particle
data was available. We then also included the concentra-
tions of PM2.5 or UFP linearly as additional adjustments
using a lag of two days, as this seemed to be the most
appropriate lag for the association between air pollution
and mortality (Breitner S et al. Unpublished work).
Results
Mortality data
There were 14,723 cardiovascular and 3,150 respiratory
deaths in the warm period, while 17,493 and 4,007 in the
cold period. Table 1 presents descriptive statistics for daily
death counts by cause and age groups, for warm and cold
periods. Deaths occurred within individuals of 65 years
and older were 83% to 88% of all cases due to each cause.
Daily death counts followed a seasonal pattern with peaks
in winters and troughs in summers in the whole popula-
tion as well as the aged people, while daily death counts
for the group of 15 to 64 years had no obvious seasonal
pattern (see Additional file 1, Figure S1).
Meteorology and air pollution
The descriptions of daily meteorological parameters and
air pollutants by time period are shown in Table 2.
Daily mean temperature, relative humidity, and baro-
metric pressure also followed seasonal patterns, but
each with different directions and magnitudes. Due to
the fact that air pollution data was only available for a
shorter time period, we couldn’t confidently detect a
seasonal pattern within this data (see Additional file 1,
Figure S2).
Regression results
Among all the exposure-response functions (Figure 2
and Additional file 1, Figure S3) between two-day or 15-
day average temperature and mortality of the whole
population due to different causes, only the association
between 15-day average temperature and mortality due
to respiratory diseases in the warm period showed J-
shaped curve (Figure 2), all the other functions could be
considered as linear. The exposure-response functions
for the elderly population had similar shapes (data not
shown).
Based on the AIC, it appeared that 21.3°C was the
most appropriate threshold temperature for the one J-
shaped relationship. The RRs of mortality associated
with mean temperature by time period and age group
are shown in Table 3. In the warm period, heat effects
were found for two-day average temperature and mor-
tality due to all causes except for ischemic heart dis-
eases. The strongest one was seen for respiratory
mortality of the whole population. For elderly people,
the RRs were lower for respiratory mortality, higher for
cerebrovascular mortality, and almost the same amount
for cardiovascular and cardiorespiratory mortality com-
pared to the whole population. Heat effect was also
found for 15-day average temperature and respiratory
mortality, but with slightly higher effect size for elderly
people. In the cold period, heat effects were also found,
for both two-day and 15-day average temperature and
respiratory mortality, also with higher effect size for the
whole population compared to the elderly. Cold effects
were found between 15-day average temperature and
mortality due to all the other four causes, as well as
between two-day average temperature and ischemic
heart diseases mortality. The sizes of the effects for
elderly people were all lower, although not much, com-
pared to those for the whole population.
Figure 3 and Additional file 1, Figure S4 together
show polynomial distributed lag curves with daily mean
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temperature for mortality of the whole population due
to all causes. In the warm period, heat effects were
always observed within the first five days, whereas a
delayed cold effect was observed only for cardiovascular
mortality and disappeared with a lag of about two
weeks. It is debatable if the described “delayed cold
effect” is real or also partly reflects a harvesting effect
(mortality displacement) following the heat effect that
might have led to an accumulation of premature deaths
in the susceptible subpopulation. In the cold period, a
heat effect was also observed for respiratory mortality.
Apparent one to eight days delayed cold effects were
observed for cardiovascular, cerebrovascular and cardi-
orespiratory mortality, showing no significant following
harvesting effect. The polynomial distributed lag curves
restricted to the elderly population were similar to the
ones for the whole population (data not shown).
Sensitivity analyses
The exposure-response curves for the whole population
obtained by using different values of smoothness for the
functions of time trend were quite robust (data not
shown). When using different threshold temperatures
(21.1, 21.2 and 21.4-21.7°C), the effects of 15-day aver-
age temperature on respiratory mortality of the whole
population as well as the elderly people in the warm
period all became slightly weaker; the size of the effect
on elderly people was still higher than the one on the
whole population (data not shown). The exposure-
response functions for apparent temperature were simi-
lar to the ones derived from the mean temperature ana-
lyses (data not shown).
The exposure-response curves for the whole popula-
tion during the shorter period showed almost no change
compared to those in Figure 2 as well as in Additional
Table 1 Descriptive statistics of daily death counts in the urban area of Beijing by time period, age group, and cause
of death
Whole population 65+ years
Warm period Cold period Warm period Cold period
Cause of death
(ICD-10 code)
Mean
± SD
Min Median Max Mean
± SD
Min Median Max Mean
± SD
Min Median Max Mean
± SD
Min Median Max
Cardiovascular
diseases (I00-I99)
28 ± 9 8 29 51 38 ± 8 17 38 70 24 ± 7 6 24 44 32 ± 7 13 32 62
Respiratory diseases
(J00-J99)
6 ± 3 0 6 17 9 ± 4 0 8 25 5 ± 3 0 5 15 8 ± 3 0 8 22
Ischemic heart
diseases (I20-I25)
12 ± 4 1 12 26 16 ± 4 5 16 35 10 ± 4 0 10 23 14 ± 4 4 13 31
Cerebrovascular
diseases (I60-I69)
12 ± 5 2 12 26 16 ± 5 4 16 33 10 ± 4 1 10 23 14 ± 4 3 13 29
Cardiorespiratory
diseases (I00-J99)
34 ± 10 10 35 62 47 ± 10 23 47 85 29 ± 9 9 29 54 40 ± 9 18 40 75
Table 2 Descriptive statistics of meteorological parameters and air pollutants in the urban area of Beijing by time
period
Time period Meteorological parameter/air pollutant Mean ± SD Min 1st Qu Median 3rd Qu Max
Warm Air temperature (°C) 22.6 ± 4.8 6.9 19.8 23.3 26.2 32.1
period Apparent temperature (°C) 23.6 ± 6.8 4.3 19.2 24.5 29.0 37.7
Relative humidity (%) 60.5 ± 18.1 10 48 63 74 95
Barometric pressure (hPa) 005.0 ± 59.5 989 1001 1005 1009 1023
PM2.5 (μg/m
3) a 105.7 ± 66.8 9.9 53.6 98.4 138.2 436.7
UFP (number/cm3) a 23940 ± 9442 9024 16920 21890 29310 73010
Cold Air temperature (°C) 3.4 ± 6.3 -9.1 -1.5 2.3 8.2 18.7
Period Apparent temperature (°C) 2.9 ± 5.5 -8.0 -1.3 1.9 6.4 18.1
Relative humidity (%) 47.8 ± 20.8 12 31 46 63 96
Barometric pressure (hPa) 1021.0 ± 65.4 999 1016 1021 1025 1037
PM2.5 (μg/m
3) a 122.0 ± 94.6 13.9 47.5 90.3 184.4 413.4
UFP (number/cm3) a 30940 ± 10637 13460 24120 29150 35550 76280
a. Particulate air pollution data were available only for the period from March 2004 on.
PM2.5: particulate matter (PM) with an aerodynamic diameter <2.5 μm.
UFP: ultrafine particles, particles with an aerodynamic diameter <0.1 μm.
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file 1, Figure S3, although the 95%CI of some curves
became wider (data not shown). The correlations
between temperature and PM2.5 as well as UFP by time
period are presented in Additional file 1, Table S2. As
shown in Additional file 1, Table S3, compared with the
effects obtained without adjustment for particle air pol-
lution, there were no relevant changes for the effects of
two-day average temperature after controlling for lag 2
of PM2.5 or UFP, either in warm or in cold period. The
effects of 15-day average temperature on cardiovascular
and cardiorespiratory mortality in the warm period
dropped and became non-significant after controlling
for lag 2 of PM2.5 or UFP; while which in the cold per-
iod only dropped after controlling for lag 2 of PM2.5.
Discussion
Summary
We only observed J-shaped association between 15-day
average temperature and respiratory mortality in the
warm period; the other associations did not diverge
from linearity. Immediate heat effects could be seen on
every outcome in the warm period, even on respiratory
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Figure 2 Exposure-response functions (together with 95% CIs) for two-day and 15-day average temperature and daily mortality of the
whole population due to cardiovascular and respiratory diseases in the urban area of Beijing, by warm/cold period.
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Table 3 Relative risks (RR, with 95% confidence intervals (CI)) of daily mortality in association with a 5°C increase of
2-day average temperature or a 5°C decrease of 15-day average temperature in the urban area of Beijing, by time
period, age group and cause of death
Warm period Cold period
RR (95%CI) per 5°C
increase of 2-day
average temperature
RR (95%CI) per 5°C
decrease of 15-day
average temperature
RR (95%CI) per 5°C
increase of 2-day
average temperature
RR (95%CI) per 5°C
decrease of 15-day
average temperature
Whole population
Cardiovascular disease (I00-
I99)
1.098(1.057,1.140) * 1.040(0.990,1.093) 0.982(0.958,1.007) 1.057(1.022,1.094) *
Respiratory disease (J00-J99) 1.134(1.050,1.224) * 0.937(0.899,0.976) *a 1.149(1.078,1.224) * 0.851(0.767,0.944) *
Ischemic heart diseases (I20-
I25)
1.020(0.975,1.067) 0.997(0.915,1.087) 0.947(0.914,0.982) * 1.123(1.057,1.193) *
Cerebrovascular diseases (I60-
I69) Cardiorespiratory diseases
(I00-J99)
1.047(1.000,1.097) * 1.025(0.950,1.106) 0.980(0.954,1.007) 1.036(1.002,1.071) *
1.114(1.076,1.153) * 1.033(0.968,1.101) 1.009(0.983,1.035) 1.057(1.006,1.111) *
65+ 65+ years
Cardiovascular disease (I00-
I99)
1.093(1.048,1.139) * 1.038(0.978,1.101) 0.994(0.965,1.023) 1.054(1.016,1.093) *
Respiratory disease (J00-J99) 1.080(1.010,1.154) * 0.931(0.890,0.973) *a 1.128(1.056,1.204) * 0.887(0.798,0.988) *
Ischemic heart diseases (I20-
I25)
1.016(0.968,1.067) 0.978(0.888,1.077) 0.954(0.920,0.990) * 1.116(1.046,1.191) *
Cerebrovascular diseases (I60-
I69)
1.064(1.008,1.123) * 1.008(0.928,1.095) 0.999(0.961,1.038) 1.031(0.978,1.087)
Cardiorespiratory diseases (I00-
J99)
1.117(1.075,1.160) * 1.010(0.941,1.084) 1.025(0.997,1.054) 1.042(1.001,1.085) *
a. Threshold model for a threshold of 21.3°C.
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mortality in the cold period; while in the cold period,
prolonged cold effects could be seen on every outcome
except for respiratory mortality. Previous studies also
found immediate heat effects and delayed cold effects
[24-26]. The strongest immediate heat effect in the
warm period was found in association with respiratory
mortality, stronger for the whole population than for
elderly people (65 years and older). However, the pro-
longed heat effect on respiratory mortality, as well as
the immediate heat effects on cardiovascular, cerebro-
vascular and cardiorespiratory mortality in the warm
period appeared with similar magnitudes for the two
age groups. The strongest cold effect in the cold period
was found in association with ischemic heart diseases
mortality, with similar effect magnitudes for the whole
as well as the elderly population. The prolonged cold
effects on cardiovascular, cerebrovascular and cardiore-
spiratory mortality in the cold period appeared also with
similar magnitudes for the two age groups. When con-
sidering PM2.5 or UFP with lag 2 as confounders, there
were no relevant changes for two-day average tempera-
ture effects, and a drop in 15-day average temperature
effects on cardiovascular and cardiorespiratory
mortalities
Heat effects
For the J-shaped exposure-response function, we found
21.3°C as our most appropriate threshold temperature.
Curriero et al. [9] got 19°C to 21°C as “minimum mor-
tality temperature” for New York (NY), Philadelphia
(PA), Baltimore (MD), Washington, D.C., U.S., while
Ballester et al. [27] got 22°C to 25°C for Valencia, Spain.
Those cities are all located on similar latitudes (from 38°
54’N to 40°54’N) as Beijing (39°54’N), and “turning-point
temperatures” were all close to each other. However,
both authors observed V-shaped temperature-mortality
functions.
For the convenience of comparison, we re-calculated
the percentages based on a 1°C increase in lag 0-1 aver-
age temperature in the warm period, which resulted in
2.5% and 1.9% increases in respiratory and cardiovascular
mortality, respectively. A study conducted in four Asian
cities including Beijing reported by Chung et al. [7]
found much higher threshold temperature (31°C) and
temperature effect estimates (10.5% and 7.6% per 1°C
increase, respectively). The fact that they used daily
apparent temperature and also included the entire Beijing
(including the suburban area with approximately
4,100,000 inhabitants, the fifth national census in 2000,
http://www.stats.gov.cn/tjsj/ndsj/renkoupucha/
2000pucha/pucha.htm) as their study area might be the
reasons for the differences. However, Almeida et al. [28]
reported estimates which are more comparable to ours in
their study in Lisbon (38°42’N), Portugal (1.7% and 2.4%
per 1°C increase, respectively) using also daily apparent
temperature. There are also studies pointing out heat
effect on ischemic mortality [26,29], which has not been
found in our results.
Similar to the present study, several authors [7,27,30,31]
observed greater effect on respiratory mortality than on
cardiovascular mortality. In our dataset, daily death counts
due to chronic lower respiratory diseases accounted for
approximately half of respiratory diseases. However, our
explorative analysis revealed that the magnitude of effect
on chronic lower respiratory diseases mortality was as
high as 98% of respiratory diseases mortality (data not
shown). This may reflect that health status of people suf-
fering from chronic respiratory diseases rapidly deterio-
rates during hot periods [31], which should be kept in
mind and considered as priority when setting up preven-
tive strategies during heat events.
After an analysis within the warm period, we found
that the order (April to September in 2003 is the 1st
warm period, April to September in 2004 is the 2nd one,
and April to August in 2005 is the 3rd one.) showed no
significant interaction with two-day average tempera-
ture, and therefore indicates that there was no heat
effect modification by potential population adaption to
heat or by possible increasing prevalence of air-condi-
tioning year by year.
Cold effects
After re-calculation of the cold effects in the cold period,
we found 1.1% and 2.3% increases in cardiovascular and
ischemic heart disease mortality of our whole study
population associated with 1°C decrease in 15-day aver-
age temperature, respectively. Analitis et al. [13] reported
a higher estimate (a 1°C decrease induced a 1.7% increase
in cardiovascular mortality in cold seasons) within the
PHEWE project, which might be attributed to their use
of a 16-day average of minimum apparent temperature.
Moreover, the PHEWE project included very cold north-
ern cities such as Helsinki and Stockholm. However, the
Eurowinter study [11] found that people in cold regions
such as Finland did not experience more winter excess
mortality than people in mild regions such as London;
Donaldson et al. [32] observed no excess ischemic heart
disease mortality as temperature fell from 10.2°C to
-48.2°C in Yakutsk, eastern Siberia. Both findings reflect
the possibility of population acclimatization to climate
and maybe also to future climate changes. However, the
associations of mortality with environmental tempera-
tures are also strongly modified by behavioural and social
factors (e.g. clothing, housing conditions) [33]. In Beijing,
the residential heating system works every year from
November 15th to next March 15th, regardless of outside
temperatures. However, we found no interaction between
heating and 15-day average temperature after an analysis
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within the cold period, showing that residential heating
didn’t modify the cold effect. This might also reflect that
the study population exposed themselves to outdoor tem-
perature although they probably spent a lot of time
indoors.
Our study showed effects of increasing temperature on
respiratory mortality even during cold season. This is con-
trary to our initial hypothesis, although the same situation
has been observed by Kunst et al. [34] in The Netherlands.
We therefore investigated the exposure-response functions
between 2-day or 15-day average temperature and mortal-
ity due to influenza and pneumonia (J10-J18) and chronic
lower respiratory diseases (J40-J47) (data not shown).
Interestingly, we observed different effects regarding the
two mortality categories. Whereas a decrease in tempera-
ture was associated with an increase in mortality due to
influenza and pneumonia (as expected), we found opposite
effects for mortality due to chronic lower respiratory dis-
eases. In a previous study, Hampel et al. [35] have reported
differences in the associations between a temperature
decrease and several blood markers of inflammation and
coagulation in patients with coronary diseases and patients
with pulmonary diseases. They hypothesized that there
might be different disease patterns as well as patient char-
acteristics and medication responsible for the observed dif-
ferences in the effects. Nevertheless, although we have no
hint of a higher misdiagnosis for respiratory deaths than
for deaths due to other causes, we cannot rule out this
possibility.
Mechanism
Some studies [36,37] have shown that respiratory mortal-
ity increases more for individuals of 65 years and older
compared to the general population when air tempera-
ture increases. One possible explanation is that aged peo-
ple, especially COPD patients, are likely to have bad
excess heat dissipation through circulatory adjustment.
The heat stress increases their risk of developing pul-
monary vascular resistance secondary to peripheral pool-
ing of blood or hypovolemia [38]. However, our results
didn’t show a higher risk for respiratory mortality in indi-
viduals of 65 years and older, although half of the respira-
tory deaths in our study period were due to chronic
lower respiratory diseases (J40-J47, mainly COPD, data
not shown). It can be speculated that aged people in Beij-
ing pay more attention and expose themselves less to
heat. Possible mechanisms through which high tempera-
ture increases cardiovascular mortality include enlarged
skin vessels and facilitated sweat, leading to falling blood
pressure, increased cardiac work load and loss of fluid
and salt, further leading to haemoconcentration [39], a
“thrombosis promoting” state. The activation of coagula-
tion and inhibition of fibrinolysis lead to diffuse micro-
vascular thrombosis. Besides, heat-induced release of
interleukin (IL)-1 or IL-6 into systemic circulation results
in damage and hyperactivation of endothelial cells.
When temperature decreases, the cold receptors in skin
are stimulated, the sympathetic nervous system regulates
the catecholamine level to increases [40] and then the
skin vessels constrict to reduce heat loss. Blood pressure
increases consequently, and approximately 1l of blood
plasma is shifted from skin and legs to central body
parts, then removed by urine or shifted to extra-cellular
space. The shift of blood plasma leads to haemoconcen-
tration, then the concentrations of red and white blood
cells, platelets, certain clotting factors, cholesterol and
fibrinogen, as well as blood viscosity all go up, promoting
clotting and thrombosis. Moreover, protein C, which is
an anticoagulant, moves out to the extra-cellular space
with blood plasma. The rise of blood pressure may lead
to oxygen deficiency in the cardiac muscle which might
induce myocardial ischemia or arrhythmias. If the rise of
blood pressure is too sudden, there is the possibility of
vascular spasm and a rupture of an atherosclerotic plaque
that induces a thrombus [39,41-43].
Strengths and limitations
This study was based on a population as large as seven
million inhabitants, among which the daily cardiorespira-
tory death count reached 40. This ensured the statistical
power of the analysis. Moreover, we did sensitivity ana-
lyses by including PM2.5 or UFP concentration levels as
confounders. Both PM2.5 and UFP [44] have been shown
to be associated with mortality. As Beijing is known as
one of the most polluted cities of the world, controlling
for these two air pollutants was an important strength of
the present study. Some other studies [36,45,46] also
considered PM2.5, PM10 or black smoke as confounders.
However, there are also limitations of the present
study. Firstly, we got both, the meteorological and the air
pollution data from only one monitoring station, which
may lead to misclassification of the exposure level. This
misclassification is non-differential and should bias the
effect estimates towards the null. However, further data
on daily meteorological parameters from an internet ser-
vice (Weather Underground 2011) was obtained for a sta-
tion located in the center of Beijing. Data from the two
sources showed a good agreement (Pearson correlation
coefficient >0.99 for air temperature). Secondly, ozone is
a potentially important confounder to heat effect, but we
had no such data for a sensitivity analysis.
Conclusions
Our results add to the evidence that both increases and
decreases in air temperature are associated with an
increased risk of cardiovascular mortality. The effects of
heat were immediate while the ones of cold became pre-
dominant with longer time lags. The increase in air
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temperature also immediately elevated the risk for
respiratory mortality.
Additional material
Additional file 1: This file contains three additional tables and four
additional figures to the manuscript. They are: - Additional file, Table
S1. Confounders included in each base model - Additional file, Table S2.
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urban area of Beijing - Additional file, Table S3. Relative risks (RR, with
95% confidence intervals (CI)) of daily mortality by cause of death and
time period in association with a 5°C increase of 2-day average
temperature or 5°C decrease of 15-day average temperature in the urban
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Indicated in each plot are the overall 29-day relative risks
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  Population                                                                                              C
onfounders 
              and O
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e 
                                                               trend          season     day of the w
eek    public       relative        barom
etric         other 
                                                                                                   (D
O
W
)                  holiday     hum
idity     pressu re 
               W
hole population                     
                  C
ardiovascular                  penalized                             dum
m
y          dum
m
y      penalized 
                   diseases (I00-I99)               spline                                  variable          variable     spline 
                  R
espiratory                        penalized     dum
m
y            dum
m
y                            penalized 
                   disease (J00-J99)               spline           variable            variable                           spline 
                  Ischem
ic heart                   penalized     dum
m
y            dum
m
y                            penalized 
                   diseases (I20-I25)               spline          variable            variable                           spline 
                  C
erebrovascular                penalized     dum
m
y            dum
m
y                            penalized                       death count due to cereborvascular diseases  
                   diseases (I60-I69)               spline          variable            variable                           spline                            of lag 1, linear 
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ardiorespiratory             penalized                              dum
m
y          dum
m
y     penalized                        
                   disease (I00-J99)                spline                                   variable          variable    spline                             
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                   diseases (I00-I99)               spline                                  variable          variable     spline 
                  R
espiratory                        penalized     dum
m
y            dum
m
y                            penalized 
                   disease (J00-J99)               spline           variable            variable                           spline 
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m
y            dum
m
y                            penalized 
                   diseases (I20-I25)               spline          variable            variable                           spline 
                  C
erebrovascular                penalized     dum
m
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m
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m
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e used the sam
e confounder m
odels for the w
arm
 and cold periods; for the sensitivity analysis w
e only re-adjusted the D
F
 for trend in every m
odel, 
because of less days, on w
hich the air pollution data w
as available.
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Additional file, Table S2. Correlations between air temperature and PM2.5 as well as UFP in 
the urban area of Beijing 
 
                                                                  PM2.5  (μg/m3)                              UFP (number/cm3) 
 
Warm period 
     Air temperature (℃)                               0.222                                     -0.297 
     PM2.5  (μg/m3)                                                                                          -0.348 
   
Cold period 
     Air temperature (℃)                               0.092                                     -0.028 
     PM2.5  (μg/m3)                                                                                          -0.417 
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 increase of 2-day average tem
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 period                                                             C
old period 
                                                                            R
R
 (95%
C
I) per 5°C
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R
 (95%
C
I) per 5°C
 
 
 
 
  
 R
R
 (95%
C
I) per 5°C
 
 R
R
 (95%
C
I) per 5°C
 
 
  
                                                                           increase of 2-day         decrease of 15-day                increase of 2-day         decrease of 15-day 
                                                                           average tem
perature     average tem
perature               average tem
perature     average tem
perature 
 T
he w
hole population 
N
o adjustm
ent for air pollutants 
      C
ardiovascular disease (I00-I99)                  1.066(1.016,1.118) *
     1.192(1.051,1.352) *            0.969(0.945,0.994) *     1.101(1.003,1.209) * 
      R
espiratory disease (J00-J99)                      1.079(0.992,1.174)        0.940(0.891,0.991) *
a          1.100(0.995,1.216)         0.930(0.769,1.125)  
      Ischem
ic heart diseases (I20-I25)                 0.999(0.941,1.061)         1.064(0.964,1.175)               0.981(0.945,1.018)        1.004(0.947,1.066)  
      C
erebrovascular diseases (I60-I69)              1.069(1.007,1.136) *     1.033(0.936,1.141)               0.978(0.941,1.016)        1.018(0.974,1.065)  
      C
ardiorespiratory diseases (I00-J99)           1.083(1.036,1.133) *     1.103(1.002,1.215) *            1.009(0.983,1.035)         1.057(1.006,1.111) * 
 PM
2.5  (linearly w
ith lag 2) 
      C
ardiovascular disease (I00-I99)                  1.082(1.024,1.144) *    1.068(0.991,1.150)               0.982(0.930,1.037)        1.041(0.944,1.147)  
      R
espiratory disease (J00-J99)                      1.079(0.986,1.181)       0.929(0.877,0.984) *
a           1.105(0.963,1.267)         0.907(0.702,1.172)  
      Ischem
ic heart diseases (I20-I25)                 1.003(0.939,1.070)       1.029(0.938,1.129)               0.962(0.920,1.005)        1.021(0.946,1.103)  
      C
erebrovascular diseases (I60-I69)              1.072(1.004,1.144) *    1.000(0.899,1.113)               1.001(0.956,1.048)         1.002(0.953,1.054)    
      C
ardiorespiratory diseases (I00-J99)           1.105(1.050,1.164) *    1.069(0.987,1.158)               1.010(0.950,1.074)          1.013(0.898,1.143)  
 U
FP (linearly w
ith lag 2) 
      C
ardiovascular disease (I00-I99)                  1.080(1.027,1.136) *     1.052(0.990,1.118)              0.970(0.944,0.998) *      1.118(1.006,1.242) * 
      R
espiratory disease (J00-J99)                      1.078(0.988,1.177)        0.933(0.880,0.989) *
a          1.115(1.000,1.244) *       1.049(0.958,1.148)  
      Ischem
ic heart diseases (I20-I25)                 1.020(0.957,1.086)        1.017(0.929,1.113)              0.971(0.933,1.011)         1.023(0.961,1.190)  
      C
erebrovascular diseases (I60-I69)              1.073(1.008,1.142) *     1.016(0.914,1.129)              0.987(0.946,1.029)         1.005(0.957,1.055)    
      C
ardiorespiratory diseases (I00-J99)           1.094(1.045,1.146) *     1.064(0.990,1.142)              1.010(0.963,1.059)          1.077(0.970,1.194)  
 
a. T
hreshold m
odel for a threshold of 21.3°C
. 
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Additional file, Figure S1. Daily death counts by cause of death and age group 
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Additional file, Figure S2. Daily mean air temperature, relative humidity, barometric 
pressure, and concentration of PM2.5† and UFP†  
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  † Particle data were available only for the period March 2004 until August 2005. 
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Additional file, Figure S3. Exposure-response relationships (together with 95% 
confidence intervals) for 2-day and 15-day average temperatures and daily mortality of 
the whole population due to ischemic heart diseases, cerebrovascular diseases and 
cardio-respiratory diseases in the urban area of Beijing, by time period 
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Additional file, Figure S4. Relative risks (together with 95% confidence intervals) of 
mortality of the whole population due to ischemic heart diseases, cerebrovascular 
diseases and cardiorespiratory diseases in association with a 5°C increase of 
temperature obtained with polynomial distributed lag models. Models were estimated 
with lags up to 29 days using a 5th degree polynomial for the cold period and the warm 
period. Indicated in each plot are the overall 29-day relative risks 
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Background: While the link between particulate matter and cardiovascular mortality is well established, it is
not fully investigated and understood which properties of the aerosol might be responsible for the health
effects, especially in polluted mega-city areas.
Objectives: Our goal was to explore the association between daily cardiovascular mortality and different
particle metrics in the sub-micrometer range in Beijing, China.
Methods: We obtained daily counts of cause-specific cardiovascular deaths in the Beijing urban area for the
period March 2004 to August 2005. Concurrently, continuous measurements of particle number size distribu-
tions were performed. Particle number concentrations (NC) between 0.003 μm and 0.8 μmwere converted to
particle mass and surface area concentrations assuming spherical particles. Semi-parametric Poisson regres-
sion models adjusting for trend, seasonality, day of the week, and meteorology were used to estimate imme-
diate, delayed and cumulative particle effects. Additionally, effect modification by air mass origin was
investigated.
Results: We observed associations between daily cardiovascular mortality and particle NC for a 2-days delay.
Moreover, nearly all particle metrics showed 2-days delayed associations with ischemic heart disease mortal-
ity. The strongest association was found for particle NC in the size range 0.03–0.1 μm (7.1% increase in daily
mortality with a 95%-confidence interval of 2.9%–11.5%, per an increase of 6250 particles/cm3). Results for
surface and mass concentrations with a lag of two days indicated effect modification by air mass origin,
whereas effects of particle NC were not modified.
Conclusions: Results show an elevated risk of cardiovascular mortality in Beijing from short-term exposure to
particulate air pollution in the sub-micrometer range. Results also indicate that locally produced smaller
particles and regionally transported particles may exhibit different effects in Beijing.
© 2011 Elsevier B.V. All rights reserved.DC, Center for Disease Control; CPC, Condensation Particle Counter; CI, confidence interval; DF, degrees of freedom; DMA,
lidation; ICD-10, International Classification of Disease, Tenth Revision; IQR, interquartile range; MC, mass concentrations;
; PAH, polycyclic aromatic hydrocarbons; PACF, partial autocorrelation coefficient; PKU, Peking University; PM, particulate
iameter b10 μm; PM2.5, particulate matter with an aerodynamic diameter b2.5 μm; PM1, particulate matter with an aero-
C1, particle NC for particles in the range below 0.8 μm; SC, surface area concentrations; SC1, particle SC for particles in the
Particle Sizer; UFP, ultrafine particles (particles with an aerodynamic diameter b0.1 μm).
n - GermanResearch Center for Environmental Health, Institute of Epidemiology II, Ingolstaedter Landstr. 1, 85764Neuherberg,
hen.de (S. Breitner).
rights reserved.
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Cardiovascular morbidity and mortality have been associated with
mass concentrations of particulate matter (PM) with an aerodynamic
diameter smaller than 10 μm or 2.5 μm (PM10 or PM2.5, respectively)
(Brook et al., 2010; Pope and Dockery, 2006). Nevertheless, questions
remain regarding the physical or chemical properties of PM responsible
for the health effects. Besides chemical composition, particle character-
istics like size, number concentration, and surface area are discussed to
determine the potential to induce inflammatory injury, oxidative
damage, and other biological effects (Brook, 2008; Valavanidis et al.,
2008).
In particular, ultrafine particles (particles with an aerodynamic
diameter less than 100 nm; UFP) may contribute to the observed health
effects because of their high particle number concentrations and larger
active surface area; thus, having a high deposition efficiency in the pul-
monary region (Brook, 2008; Delfino et al., 2005; Pekkanen andKulmala,
2004; Peters et al., 2006). UFP can be further divided into two sub-
fractions: Nucleation mode particles and Aitken mode particles. Nucle-
ationmode particles are often defined as particles with an aerodynamic
diameter less than b0.03 μm, whereas Aitken mode particles are then
defined as particles with an aerodynamic diameter between 0.03 and
0.1 μm; see, for example, Halonen et al. (2009) or Peters et al. (2009)
(it should be noted, however, that there are also studies using different
size ranges for Nucleation mode and Aitken mode particles; see, for
example, Yue et al., 2009 or Branis et al., 2010). Both sub-fractions differ
in dynamics and may also have varying effects on health. Nucleation
mode particles mainly result from gas-to-particle conversion of differ-
ent chemical compounds. Aitken mode particles, on the other hand,
are directly emitted from combustion processes, such as soot particles
from car traffic. They may also result from condensational growth and
coagulation of nucleation mode particles. Aerosols in the accumulation
mode (0.1–0.8 μm; ACP) are generally produced by the coagulation of
smaller particles and by the heterogeneous nucleation of condensable
vapors onto existing aerosol particles.
Due to the limited availability of appropriate measurement data,
there are only few epidemiological studies on the short-term associa-
tions between daily cardiovascular mortality and more accurately
size-segregated particles (Atkinson et al., 2010; Branis et al., 2010;
Halonen et al., 2009; Peters et al., 2009; Stölzel et al., 2003). Nearly all
studies on health effects of smaller particles have been conducted in
North America and Europe; there remains a need for replicating these
findings in China, as there are different concentration levels. There
might be also differences in specific sources and their proportional
contributions to the air pollution mixture, which might influence size
distribution and chemical composition of particles and the associations
between particles and human health.
This study aimed to investigate whether daily changes in ambient
concentrations of particle size fractions in the sub-micrometer range
are associated with cause-specific cardiovascular mortality in different
age groups in Beijing, China. Moreover, we aimed to better delineate
whether particle number, mass, or surface area concentrations may be
responsible for the associations. Additionally, we investigatedmodifica-
tions of air pollution effects by air mass origin defined by backward
trajectories.2. Material and methods
2.1. Study area and period
The study was conducted in the urban area of Beijing, China, from
March 4, 2004 to August 31, 2005 (546 days). Beijing is located about
150 km southeast of the Bohai Sea, and is surrounded by mountains
in the north, northwest, and west. In 2005, the Beijing urban area
comprised eight districts with a total area of about 1368 km2 and42had a population size of approximately 10 million inhabitants
(Beijing Municipal Bureau of Statistics, 2006) [Appendix A, Fig. A.1].
2.2. Mortality data
Cardiovascular death count data for adult residents (age≥15 years)
were obtained from the Beijing Center for Disease Control (CDC) for the
urban area of Beijing. The Beijing CDC provided data including five-year
age groups and the code for the underlying cause of death which was
classified according to the International Classification of Disease, 10th
Revision (ICD-10). Cardiovascular mortality was divided into the
following causes: cardiovascular diseases (ICD-10: I00–I99), ischemic
diseases (ICD-10: I20–I25), and stroke (ICD-10: I60–I69). We did not
consider further disease-specific analysis due to the low number of
cases in the relevant subgroups. Age-specific death counts were com-
bined to adult mortality (age≥15 years) as well as mortality of elderly
people (age ≥65 years).
2.3. Air pollution and meteorological data
Data on particle number size distribution were taken on the
campus area of the Peking University (PKU), located in the Haidian
district in the north western part of Beijing [Appendix A, Fig. A.1].
The setup of the measurement station was already described in detail
elsewhere (e.g. Wehner et al., 2004, 2008). The measurement station
can be classified as an urban background station (Wehner et al., 2004)
and is a few hundred meters away from a major road, the fourth ring
road. The campus is primarily a residential and commercial area with-
out any industrial or agricultural activities. Local emission sources
within a radius of 1 km were vehicular traffic, fuel combustion by do-
mestic cooking and heating, and construction. Average particle number
size distributions at the PKU measurement site and another regional
measurement site, located around 50 km to the south of the PKU,
were shown to be similar in summer (Yue et al., 2009), especially dur-
ing regional pollution periods, confirming that the PKU measurement
site may be considered as an urban background station.
In this study, we obtained data on number size distributions in the
size range between 0.003 and 0.8 μm. A Twin Differential Mobility
Particle Sizer (TDMPS) system (Birmili et al., 1999) was used to sample
the size distributions between 0.003 and 0.8 μm (mobility diameter). In
this instrument, aerosol particles are charged in a bipolar diffusion char-
ger, leading to a size-dependent charge equilibrium. For each particle
size, the fractions of positively and negatively as well as for uncharged,
singly andmultiple charged particles are known. In a DifferentialMobil-
ity Analyzer (DMA), fractions of particles with the same electrical mo-
bility are selected by scanning the voltage between the electrodes of
the capacitor. The mobility distribution is determined by measuring
the number concentration of the selected electrical mobilities by a Con-
densation Particle Counter (CPC). Knowing the bipolar charged distri-
bution and the transfer function of the DMA, the real number size
distribution can be calculated. The TDMPS used in this study consists
of twomobility size spectrometers. The measured mobility distribution
were merged here and then inverted as once to the number size distri-
bution. Losses by diffusion of particles smaller 0.1 μm were corrected
after the inversion to obtain the final number size distribution. A low-
flow PM10 inlet was used to minimize contamination by large dust par-
ticles and data were corrected for sedimentation within the inlet line
(Wehner et al., 2004).
To ensure the data quality, checks of the TDMPS systems were
done on a regular base. First, the flow rates of the DMAs and CPCs
were checked weekly. Flow sensors were recalibrated if necessary.
Furthermore, sizing of the mobility size spectrometers were checked
every three month using latex particles of 200 as an independent
check of the sheath air flow of the DMA. The accuracy of the date
was about +/−10% in terms of the concentration and 2% in terms of
sizing. The relative humidity within the systems was kept below 30%
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cycle to reduce dependence of measured properties on relative humid-
ity (Wu et al., 2008) and avoid condensation of water in the inlet
systems during warm and humid days, especially during summertime.
Number size distributions were converted to particle number con-
centrations (NC), particle surface area concentrations (SC) assuming
spherical particles (Leitte et al., 2011) and then to particle mass con-
centrations (MC) assuming a density of 1.5 g/cm³ (Wehner et al.,
2008). For the present analysis, we computed daily means of these
particle metrics for several size ranges: 0.003–0.03 μm (Nucleation
mode), 0.03–0.1 μm (Aitken mode), 0.1–0.3 μm, 0.3–0.8 μm, and
0.003–0.8 μm.
As shown in Fig. 1, particles in the ultrafine range were mainly
represented by number, whereas ACP (0.1–0.8 μm) were mostly
represented by mass and surface area. Based on these proportions,
for Nucleation and Aitken mode particles we only analyzed NC in
association with mortality, whereas for ACP we only investigated
MC and SC.
Daily meteorological data were available at two locations, one in a
distance of about 400 m from the air sampling site, the second in a
distance of about 30 km of the air measurement station (Chinameteoro-
logical data sharing service system, World Meteorological Organization
(WMO) station number 54511, see Appendix A, Fig. A.1). The data
obtained included average daily temperature and relative humidity and
were highly correlated (Spearman correlation coefficients between the
two data sources were around 0.99). As the weather data obtained near-
by the particle monitoring site contained missing values, we used data
from theWMO station.
Data on air mass history could be obtained from an analysis by
Wehner et al. (2008). Back-trajectories with a length of 72 h were
used to determine the origin of air masses. Classification of the back-
trajectories by cluster analysis was applied which resulted in 6
different clusters (cluster 1–cluster 6). Clusters 1–4 represent air
masses arriving from northerly directions with average to high wind
speed, while clusters 5 and 6 consist of air masses coming from the
south with low wind speed to stagnant conditions.
2.4. Statistical analysis
2.4.1. Statistical model
We used quasi-likelihood estimation within the context of Poisson
semi-parametric regression models to model the natural logarithm of
the expected daily death counts as a function of the predictor variables.3-30nm 30-100nm 0.1-0.3µm 0.3-0.8µm
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Fig. 1. Particle size ranges and contributions to number (NC), surface (SC), and mass
(MC) concentration.
43Penalized splines based on B-spline bases were used to allow for non-
linear confounding effects (Eilers and Marx, 1996).
In a first step, a basemodelwas built without air pollutants. To con-
trol for systematic variation over time, we introduced a time trend and
seasonality term as well as dummy variables for day of the week and
public holidays. As other potential confounders we considered daily
mean air temperature and relative humidity.
To ensure sufficient adjustment for season and meteorology, time
trend and air temperature were forced into the base model. The abso-
lute value of the sum of the partial autocorrelation function (PACF)
was used to guide the selection of degrees of freedom (DF) for time
trend (Touloumi et al., 2006). Model selection for the other confounder
variables was carried out by minimizing the Generalized Cross Valida-
tion (GCV) criterion (Wood, 2006). For the meteorological parameters
we considered lags 0 to 14, the mean of lags 0 and 1, the mean of lags
0–4, and the mean of lags 0–14.
In the final confounder model, the number of DF for the smooth
function of time trend was re-adjusted, as many of the meteorological
variables exhibit seasonal patterns themselves and, hence, capture
part of the observed seasonal trends in the outcome (Touloumi et
al., 2004). The final confounder model consisted of smooth functions
of trend, 2-day average air temperature (representing the effect of
higher temperatures), 15-day average air temperature (representing
the effect of colder temperatures), and same-day relative humidity
as well as day of the week.
In the last step of the analysis, particle metrics were added sepa-
rately to the models and associations estimated linearly. We analyzed
single-day lags from 0 to 3 days, and the average of days 0–4 (5-day
mean). We also investigated the associations between air pollution
and cardiovascular mortality for elderly people (≥65 years) only.
Further, two-pollutant models examined the independent effects of
particle metrics. To avoid problems with collinearity, these analyses
were only conducted when the pollutants' inter-correlation was b0.5.
Lags with the absolute greatest single-day effect were included in
these two-pollutant models. Finally, we also investigated modification
of the particle metric effects by air mass origin. For our analyses, we de-
fined a dummy variable with ones when air masses were classified into
stagnant and southern air masses (clusters 5 and 6 obtained byWehner
et al. 2008) versus zeros when air masses arrived from northerly direc-
tions with average to high wind speed (clusters 1 to 4). Interaction
termswere added to themodels in order to estimate the particle effects
of the corresponding subgroups. We used a likelihood ratio test to
determine whether there were indeed differences between the
subgroups.2.4.2. Sensitivity analyses
To explore the robustness of the models, we performed sensitivity
analyses using different values of smoothness for the functions of
time trend and air temperature, but also a different air temperature
measure, apparent temperature. Moreover, we excluded all days,
which have been previously identified as days with dust events
(Wu et al., 2009). We further checked the exposure–response func-
tions for deviations from linearity. Therefore, we replaced the linear
term of the particle metrics with a fixed 4DF regression spline. A
likelihood ratio test with 3DF that compares the original main
model with the smoothed model and visual inspection were used to
assess whether the smoothed exposure–response curve resembles a
straight line. Additionally, we compared different values of smooth-
ness by the generalized cross-validation (GCV) score.
Data were analyzed using the package “mgcv” version 1.5.5 in the
statistical software R version 2.9.2 (R Development Core Team,
2009). Effect estimates are presented as percent change in mortality
together with 95% confidence intervals (CI) based on an increase in
air pollution concentrations from the first to the third quartile
[interquartile range (IQR)].
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3.1. Descriptives
Overall, there were 15,769 cardiovascular deaths during the study
period from March 4, 2004 to August 31, 2005. Ischemic heart dis-
eases and cerebrovascular diseases were the two major death causes
for cardiovascular mortality; each category accounted for around 42%
of the deaths. Elderly people (≥65 years) accounted for at least 75%
for all causes of death.
Descriptive parameters of death counts, particle metrics, and
meteorological data are provided in Table 1. Daily death counts and
meteorological variables followed a seasonal pattern (data not
shown). The time series of size-segregated particle NC, MC, and SC
contained some gaps due to measurement equipment maintenance.
Overall, 11% of the TDMPS measurements were missing (Table 1).
For Aitken mode particles, there were almost no differences in NC
when air masses came from different directions (Table 1), whereas
for particles in the range below 0.8 μm (NC1) NC were slightly higher
for stagnant and southern air masses. The same pattern was seen for
SC and MC of particles below 0.8 μm (SC1 or MC1, respectively).
Most of the particle number concentration (76.5%) was in the UFP
fraction, with nearly same proportions for Nucleation particles and
Aitken mode particles (37.4% and 39.1%, respectively) (Fig. 1). In
contrast, most of the surface area (83.7%) and nearly all mass
(95.7%) were attributable to particles in the size range of 0.1–0.3 μm
and 0.3–0.8 μm.
Nucleation mode particles were not correlated with Aitken mode
particles (Spearman correlation coefficient r=0.17) and moderately
negatively correlated with nearly all other air pollution parameters
and relative humidity (−0.55≤r≤−0.67, see Appendix A, Table A.1).
Aitken mode particles and particles in the range below 0.8 μm (NC1)
were not or only slightly correlated with all other parameters, whereasTable 1
Descriptive statistics for mortality counts, particle number (NC), particle surface (SC), and p
Beijing, China, from March 2004 to August 2005.
Min
Deaths
Cardiovascular disease (I00–I99) 8
Coronary heart disease (I20–I25) 1
Cerebrovascular disease (I60–I69) 2
Pollutants a
NC Nucleation mode (b0.03 μm) [cm−3] 2522
NC Aitken mode (0.03–0.1 μm) [cm−3] 2103
NC1 (b0.8 μm) [cm−3] 12,370
SC 0.1–0.3 μm [μm2 cm−3] 67.1
SC 0.3–0.8 μm [μm2 cm−3] 35.6
SC1 (b0.8 μm) [μm2 cm−3] 137.5
MC 0.1–0.3 μm [μg/m3] 3.2
MC 0.3–0.8 μm [μg/m3] 4.1
MC1 (b0.8 μm) [μg/m3] 8.0
Pollutants a — Air mass origin
NC Aitken mode (0.03–0.1 μm) [cm−3]
Southern and stagnant air masses 2135
Northerly directions with average to high wind speed 2103
NC1 (b0.8 μm) [cm−3]
Southern and stagnant air masses 12,720
Northerly directions with average to high wind speed 15,020
SC1 (b0.8 μm) [μm2 cm−3]
Southern and stagnant air masses 147.8
Northerly directions with average to high wind speed 144.3
MC1 (b0.8 μm) [μg/m3]
Southern and stagnant air masses 9.2
Northerly directions with average to high wind speed 8.8
Meteorological variables
Air temperature [°C] −7.1
Relative humidity [%] 10.0
a 11% of the daily values are missing.
44MC and SC were highly correlated with each other in the accumulation
mode range.
3.2. Regression results
Regression results showed an association between daily cardiovas-
cular mortality and particle NC in the Aitken mode range as well as
NC1 (Table 2). We observed the strongest associations for a delay of
two days. Whenmortality due to ischemic heart diseases was separate-
ly analyzed, we found a consistent 2-days-delayed association with all
particle metrics except with particle NC in the nucleation mode range
(Table 2). Cerebrovascular mortality only had borderline significant
associations with particle NC (data not shown) with a delay of two
days as well as with the 5-day average.
Associations between particle metrics and cardiovascular mortality
for elderly people (≥65 years) showed similar effects compared to the
results found for the adult population (Fig. 2). The same was the case
for mortality due to ischemic heart diseases (Fig. 2) as well as for
mortality due to cerebrovascular diseases (data not shown).
Two-pollutant models showed that the association between cardio-
vascular mortality and Aitken mode particles as well as particle NC in
the range below0.8 μm(NC1)was not confounded by any other particle
metrics (Table 3). For Aitken mode particles, risk estimates in ischemic
heart disease mortality were also essentially unchanged or only de-
creased slightly, while the effects for SC and MC diminished (Table 3).
In two-pollutant models with NC of particles in the range below
0.8 μm (NC1) associations for all particle metrics slightly decreased,
but were still significant.
Associations between cardiovascular and ischemic heart disease
mortality and particle NC in the Aitken mode range and in the range
below 0.8 μm (NC1) were not modified by air mass origin (Fig. 3). In
contrast, results indicated that mortality effects of SC and MC with a
lag of two days were stronger for stagnant and southern air massesarticle mass (MC) concentrations, and meteorological parameters in the urban area of
25% 50% 75% Max
23 30 35 54
9 12 15 26
9 12 15 33
6917 10,430 17,120 61,930
10,130 13,260 16,380 31,080
26,900 33,500 40,690 86,820
350.8 567.0 819.6 2076.0
192.4 400.2 679.1 2631.0
713.3 1155.0 1687.0 4849.0
16.2 27.8 40.2 105.1
22.5 47.3 80.4 319.4
42.1 78.4 123.9 422.9
9516 12,500 16,500 30,500
10,270 13,390 16,410 28,970
27,090 35,500 41,470 86,820
26,200 33,100 40,550 78,640
829.2 1181.0 1728.0 4849.0
700.7 1148.0 1682.0 4796.0
48.9 82.0 136.8 405.0
40.5 78.0 123.9 422.9
7.60 18.7 24.3 32.1
36.0 56.0 73.0 93.0
Table 2
Percentage of change (95%-confidence interval) in cardiovascular (ICD-10 I00–I99) and
ischemic heart disease (ICD-10 I20–I25) mortality per an interquartilea increase in pol-
lutants in Beijing, from March 2004 to August 2005.b
Air pollutant and lag Cardiovascular mortality
% Change (95% CI)
Ischemic heart disease
mortality % Change (95% CI)
Nucleation mode (b0.03 μm) [cm−3]
0 0.75 (−2.35;3.96) 3.57 (−1.21;8.58)
1 0.74 (−2.02;3.57) 2.33 (−1.88;6.73)
2 1.16 (−1.39;3.78) −1.57 (−5.29;2.30)
3 1.52 (−0.98;4.07) 0.45 (−3.29;4.34)
5 d-average 2.13 (−1.80;6.22) 1.68 (−4.14;7.85)
Aitken mode (0.03–0.1 μm) [cm−3]
0 0.30 (−2.63;3.31) −0.70 (−5.01;3.80)
1 −1.48 (−4.44;1.58) −2.04 (−6.38;2.50)
2 4.04 (1.18;6.98) ⁎⁎⁎ 7.13 (2.91;11.52) ⁎⁎⁎
3 1.57 (−1.22;4.43) 3.17 (−0.93;7.43)
5 d-average 2.99 (−0.66;6.77) 3.99 (−1.03;9.25)
NC1 (b0.8 μm) [cm−3]
0 0.59 (−2.93;4.24) 0.86 (−4.40;6.41)
1 0.21 (−3.2;3.78) 1.19 (−4.01;6.66)
2 4.92 (1.50;8.45) ⁎⁎⁎ 6.59 (1.50;11.93) ⁎⁎
3 2.79 (−0.57;6.27) 3.78 (−1.17;8.99)
5 d-average 4.19 (−0.76;9.37) ⁎ 5.30 (−1.77;12.88)
SC 0.1–0.3 μm [μm2 cm−3]
0 −0.56 (−3.38;2.35) −3.32 (−7.39;0.93)
1 0.38 (−2.18;3.00) −0.32 (−4.03;3.53)
2 0.93 (−1.42;3.34) 4.47 (1.05;8.01) ⁎⁎
3 −0.27 (−2.56;2.06) 1.36 (−1.99;4.82)
5 d-average 0.24 (−2.72;3.29) 1.22 (−2.72;5.32)
SC 0.3–0.8 μm [μm2 cm−3]
0 −0.59 (−3.18;2.07) −3.5 (−7.27;0.42)
1 0.52 (−1.69;2.70) 1.30 (−1.95;4.67)
2 0.41 (−1.66;2.50) 3.71 (0.71;6.79) ⁎⁎
3 −1.05 (−3.03;0.97) −0.40 (−3.31;2.59)
5 d-average −0.48 (−3.49;2.63) 0.85 (−3.34;5.23)
SC1 (b0.8 μm) [μm2 cm−3]
0 −0.59 (−3.36;2.26) −3.61 (−7.61;0.56)
1 0.42 (−2.02;2.93) 0.54 (−3.03;4.23)
2 0.85 (−1.41;3.16) 4.51 (1.24;7.89) ⁎⁎⁎
3 −0.68 (−2.85;1.53) 0.52 (−2.65;3.79)
5 d-average −0.01 (−3.07;3.15) 1.25 (−2.87;5.55)
MC 0.1–0.3 μm [μg/m3]
0 −0.57 (−3.40;2.33) −3.50 (−7.58;0.76)
1 0.43 (−2.11;3.03) −0.18 (−3.87;3.66)
2 0.86 (−1.48;3.26) 4.47 (1.06;8.01) ⁎⁎
3 −0.34 (−2.61;1.99) 1.24 (−2.10;4.70)
5 d-average 0.13 (−2.87;3.23) 1.16 (−2.87;5.36)
MC 0.3–0.8 μm [μg/m3]
0 −0.61 (−3.18;2.03) −3.40 (−7.14;0.49)
1 0.46 (−1.73;2.70) 1.31 (−1.90;4.64)
2 0.33 (−1.71;2.42) 3.54 (0.58;6.58) ⁎⁎
3 −1.07 (−3.03;0.92) −0.46 (−3.33;2.50)
5 d-average −0.53 (−3.52;2.55) 0.82 (−3.33;5.15)
MC1 (b0.8 μm) [μg/m3]
0 −0.63 (−3.34;2.15) −3.64 (−7.55;0.45)
1 0.47 (−1.87;2.86) 0.99 (−2.43;4.53)
2 0.52 (−1.65;2.73) 4.00 (0.867.23) ⁎⁎
3 −0.93 (−3.00;1.19) −0.02 (−3.07;3.11)
5 d-average −0.37 (−3.47;2.84) −0.72 (−3.26;5.45)
a Interquartile range for nucleation mode: single lags=10,203 cm−3, 5-day average=
7448 cm−3; Aitken mode: single lags=6250 cm−3, 5-day average=4150 cm−3; NC1:
single lags=13,790 cm−3, 5-day average=12,060 cm−3; SC 0.1–0.3 μm: single
lags=468.8 μm2 cm−3, 5-day average=265.9 μm2 cm−3; SC 0.3–0.8 μm: single lags=
486.7 μm2 cm−3, 5-day average=361.9 μm2 cm−3; SC1: single lags=973.7 μm2 cm−3,
5-day average=630.2 μm2 cm−3; MC 0.1–0.3 μm: single lags=24.0 μg/m3, 5-day
average=14.0 μg/m3; MC 0.3–0.8 μm: single lags=57.9 μg/m3, 5-day average=
43.4 μg/m3; MC1: single lags=81.8 μg/m3, 5-day average=58.1 μg/m3.
b Models adjusted for trend, weekday, temperature (2-day average and 15-day average),
and relative humidity (lag 0).
⁎ p-valueb0.10.
⁎⁎ p-valueb0.05.
⁎⁎⁎ p-valueb0.01.
5200 S. Breitner et al. / Science of the Total Environment 409 (2011) 5196–5204compared to air masses arriving from northerly directionswith average
to high wind speed, although the interaction term was not statistically
significant. An increase of 973.7 μm2 cm−3 in the SC of particles below450.8 μm (SC1) resulted in a 5.7% increase (95% CI: 0.18%; 11.41%) in
ischemic heart disease mortality for stagnant and southern air masses
compared to a 2.8% increase (95% CI: −1.38%; 7.21%) for air masses
from northerly directions with average to high wind speed. Moreover,
an increase of 81.8 μg/m3 in the MC of particles below 0.8 μm (MC1)
resulted in a mortality increase of 5.17% (95% CI: 0.01%; 10.60%) for
stagnant and southern air masses, while for air masses from northerly
directionswith average to highwind speedwe observed a 2.3% increase
(95% CI: −1.79%; 6.59%).
3.3. Sensitivity analyses
We performed a number of sensitivity analyses (Appendix A,
Table A.2), resulting in only slight changes of the risk for mortality.
Different values of smoothness for the exposure–response relation-
ships between particle NC and mortality and corresponding likelihood
ratio tests indicated linear exposure–response relationships (data not
shown).
4. Discussion
We observed adverse associations between particle NC and cardio-
vascular mortality for a 2-days delay. Moreover, all particle parameters
except particle NC below 30 nm showed 2-days-delayed associations
with ischemic heart disease mortality. The strongest association was
found for NC of particles in the size range 0.03–0.1 μm. This association
also did not change when adjusting for other particle metrics. Mortality
effects of particle NC were not modified by air mass origin. In contrast,
results for SC and MC with a lag of two days indicated stronger effects
for stagnant and southern air masses compared to air masses arriving
from northerly directions with average to high wind speed.
There are only a small number of studies on cardiovascularmortality
that also have considered particle NC. Studies conducted in Erfurt,
Germany, reported delayed increases of 5.1% (95% CI: −1.0;11.5) as
well as of 3.1% (95% CI: 0.2;6.0) in cardiovascular mortality per
increases of 12,690 cm−3 (Wichmann et al., 2000) and 9743 cm−3
particles (Peters et al., 2009; Stolzel et al., 2007) in the size range of
0.01–0.1 μm. Moreover, a recent study reported that out of a larger
number of particlemetrics, only particle NCwas associatedwith cardio-
vascular mortality (increase of 2.2% (95% CI: 0.6;3.8) per increase of
10,166 cm−3 particles), although the increase was seen more immedi-
ately with a lag of one day (Atkinson et al., 2010). In our study, particle
NC showed a delayed association with cardiovascular mortality. For
comparative purposes, we re-calculated our results based on an in-
crease of 10,000 particles/cm3 which resulted in a 6.5% (95% CI:
1.9;11.4) increase in cardiovascularmortality in associationwith Aitken
mode particles and a 3.5% (95% CI: 1.1;6.1) increase for NC1, respective-
ly. In contrast, Branis et al. (2010) and Halonen et al. (2009) did not find
any association between particle NC and cause-specific mortality, in-
cluding cardiovascularmortality, for the CzechRepublic and Finland, re-
spectively. We did not find any association between cardiovascular
mortality and particle MC and SC which is, for MC, in agreement with
the studies conducted in Erfurt (Peters et al., 2009; Stolzel et al.,
2007), but in contrast to a study recently conducted in Barcelona
(Perez et al., 2009).
For ischemic heart disease mortality the strongest associations
were seen for NC of particles; a result also found by Forastiere et al.
(2005) who showed a significant increase of out-of-hospital coronary
deaths in Rome, Italy, in association with an increase in same-day
UFP. Moreover, our results also indicated delayed associations with
sub-micrometer particle MC and SC. Note that we did not measure ac-
tive particle surface area directly on a continuous scale, but only could
obtain calculated surface area concentrations by converting particle
numbers. Nevertheless, toxicological studies report that surface area
plays an important role in determining the biological activity of parti-
cles (Brook, 2008; Valavanidis et al., 2008).
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Fig. 2. Percentage of change (95%-confidence interval) in cause- and age-specific car-
diovascular mortality per an interquartile a increase in particle metrics in Beijing b,
from March 2004 to August 2005. a Interquartile range for nucleation mode:
10,203 cm−3; Aitken mode: 6250 cm−3; NC1: 13,790 cm−3; SC 0.1–0.3 μm:
468.8 μm2 cm−3; SC 0.3–0.8 μm: 486.7 μm2 cm−3; SC1: 973.7 μm2 cm−3; MC 0.1–
0.3 μm: 24.0 μg/m3; MC 0.3–0.8 μm: 57.9 μg/m3; MC1: 81.8 μg/m3. b Beijing urban area.
Table 3
Percentage of change (95%-confidence interval) in cardiovascular (ICD-10 I00–I99) and
ischemic heart disease (ICD-10 I20–I25) mortality per an interquartilea increase in pol-
lutants with a lag of 2 days in Beijing, fromMarch 2004 to August 2005b. Two-pollutant
modelsc.
Air
pollutant
Cardiovascular mortality
%change (95% CI)
Ischemic heart disease
mortality %change (95% CI)
Two-pollutant Two-pollutant
Aitken mode 4.29 (1.40;7.26)⁎⁎⁎ 7.03 (2.76;11.48)⁎⁎⁎
Nucleation mode 1.67 (−0.90;4.31) −0.55 (−4.33;3.38)
Aitken mode 4.52 (1.27;7.88)⁎⁎⁎ 5.84 (1.00;10.91)⁎⁎
SC 0.1–0.3 μm −0.82 (−3.43;1.85) 1.99 (−1.88;6.02)
Aitken mode 4.06 (1.16;7.06)⁎⁎⁎ 6.26 (1.97;10.73)⁎⁎⁎
SC 0.3–0.8 μm −0.10 (−2.17;2.02) 2.66 (−0.37;5.78)⁎
Aitken mode 4.24 (1.15;7.43)⁎⁎⁎ 5.68 (1.09;10.47)⁎⁎
SC1 −0.42 (−2.81;2.04) 2.59 (−0.94;6.26)
Aitken mode 4.42 (1.24;7.69)⁎⁎⁎ 5.81 (1.09;10.75)⁎⁎
MC 0.1–0.3 μm −0.70 (−3.24;1.91) 2.19 (−1.59;6.11)
Aitken mode 4.07 (1.17;7.06)⁎⁎⁎ 6.32 (2.03;10.78)⁎⁎⁎
MC 0.3–0.8 μm −0.15 (−2.20;1.95) 2.53 (−0.45;5.61)⁎
Aitken mode 4.13 (1.17;7.18)⁎⁎⁎ 6.04 (1.66;10.61)⁎⁎⁎
MC1 −0.28 (−2.49;1.98) 2.58 (−0.67;5.92)
NC1 4.83 (1.36;8.42)⁎⁎⁎ 5.31 (0.15;10.73)⁎⁎
SC 0.1–0.3 μm 0.34 (−2.02;2.75) 3.60 (0.12;7.20)⁎⁎
NC1 4.91 (1.49;8.45)⁎⁎⁎ 6.17 (1.11;11.48)⁎⁎
SC 0.3–0.8 μm 0.38 (−1.67;2.47) 3.43 (0.46;6.50)⁎⁎
NC1 4.83 (1.39;8.39)⁎⁎⁎ 5.43 (0.33;10.80)⁎⁎
SC1 0.43 (−1.82;2.74) 3.82 (0.52;7.22)⁎⁎
NC1 4.84 (1.38;8.41)⁎⁎⁎ 5.40 (0.26;10.80)⁎⁎
MC 0.1–0.3 μm 0.34 (−2.00;2.74) 3.67 (0.21;7.24)⁎⁎
NC1 4.92 (1.50;8.45)⁎⁎⁎ 6.21 (1.15;11.53)⁎⁎
MC 0.3–0.8 μm 0.32 (−1.70;2.39) 3.29 (0.35;6.32)⁎⁎
NC1 4.89 (1.46;8.43)⁎⁎⁎ 5.91 (0.8;11.24)⁎⁎
MC1 0.35 (−1.80;2.55) 3.56 (0.43;6.7)⁎⁎
a Interquartile range for nucleation mode (b0.03 μm): 10,203 cm−3; Aitken mode
(0.03–0.1 μm): 6250 cm−3; NC1 (b0.8 μm): 13,790 cm−3; SC 0.1–0.3 μm: 468.8 μm2
cm−3; SC 0.3–0.8 μm: 486.7 μm2 cm−3; SC1 (b0.8 μm): 973.7 μm2 cm−3; MC 0.1–
0.3 μm: 24.0 μg/m3; MC 0.3–0.8 μm: 57.9 μg/m3; MC1 (b0.8 μm): 81.8 μg/m3.
b Models adjusted for trend, weekday, temperature (2-day average and 15-day
average), and relative humidity (lag 0).
c Two-pollutant models were only conducted when the pollutants' inter-correlation
was b0.5.
⁎ p-valueb0.10.
⁎⁎ p-valueb0.05.
⁎⁎⁎ p-valueb0.01.
5201S. Breitner et al. / Science of the Total Environment 409 (2011) 5196–5204We found no consistent associations between sub-micrometer
particle metrics and cerebrovascular mortality; a finding which is
supported by a study conducted in Helsinki, Finland (Halonen et al.,
2009). However, Perez et al. (2009) found an increase of 5.6% (95%
CI: 0.3;11.3) in cerebrovascular mortality for a 10 μg/m3 increase of
MC1 in a study conducted in Barcelona.
In models controlling for other particle metrics, particle NC
showed an independent effect of other particle metrics which is in
agreement with other studies (Atkinson et al., 2010; Peters et al.,
2009). Associations for particle MC and SC generally diminished
when controlling for NC of Aitken mode particles, but showed only
slight changes in association with ischemic heart disease mortality
when controlling for NC1.
The associations between particle SC and MC and cardiovascular
mortality were elevated for stagnant and southern air masses. It has
been shown that during days with higher air pollution air masses
mostly arrive from densely populated and industrial regions south
and south-east of Beijing (Massling et al., 2009; Wehner et al.,
2008). These slow-moving air masses highly influence the accumula-
tion mode aerosol in Beijing and in the whole China Plain by aged re-
gional aerosol and secondary aerosol production (Wiedensohler et al.,
2009). Chemically and physically altered particles transported by air
masses from regions south and south-east of Beijing might be respon-
sible for the stronger associations observed in our study. On the other46hand, when air masses arrive from Central Asia the lowest particle MC
is observed in Beijing (Wehner et al., 2008; Zhang et al., 2010). Health
effects of particle NC on cardiovascular mortality were not modified
by air mass origin. These results indicate that locally produced ultra-
fine particles and regionally transported ACP may exhibit different ef-
fects in Beijing.
Overall, results point to a strong role of particles in the Aitken
mode range. It has been shown that particle NC of Aitken mode par-
ticles such as soot are strongly influenced by traffic emissions,
which is also the case in Beijing (Wu et al., 2008). Therefore, these
soot particles may contain a significant amount of polycyclic aromatic
hydrocarbons (PAH) and toxic metals, through which they may neg-
atively affect human health (Branis et al., 2010; Ning and Sioutas,
2010).
There were on average 29 daily deaths due to cardiovascular dis-
eases in our study period which ensured the statistical power of the
analysis. Moreover, we thoroughly adjusted for meteorological con-
founder variables as well as time trend to rule out the possibility
that the detected associations resulted from meteorological influ-
ences or seasonal differences. Additional sensitivity analyses indicat-
ed that our final models seemed to be conservative and stable with
respect to the choice of the model parameters.
Nevertheless, this study also has some limitations. Many of the
metrics under investigation may vary considerably in space. There-
fore, a greater amount of measurement error due to greater spatial
variability could be present in this study as we only had
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Fig. 3. Percentage of change (95%-confidence interval) in cardiovascular (ICD-10 I00–
I99) and ischemic heart disease (ICD-10 I20–I25) mortality per an interquartile a in
crease in particle metrics in Beijing b, from March 2004 to August 2005. Effect modifi
cation by air mass origin. a Interquartile range for nucleation mode: 10,203 cm−3
Aitken mode: 6250 cm−3; NC1: 13,790 cm−3; SC 0.1–0.3 μm: 468.8 μm2 cm−3; SC
0.3–0.8 μm: 486.7 μm2 cm−3; SC1: 973.7 μm2 cm−3; MC 0.1–0.3 μm: 24.0 μg/m3; MC
0.3–0.8 μm: 57.9 μg/m3; MC1: 81.8 μg/m3. b Beijing urban area.
Table A.1
Spearman rank correlation for daily means of air pollutants and meteorological param
Nucleation
mode
Aitken
mode
NC1 SC 0.1–0.3
µm
Nucleation
mode 1.00
Aitken mode 0.17 1.00
NC1 0.57 0.80 1.00
SC 0.1–0.3 µm –0.55 0.45 0.21 1.00
SC 0.3–0.8 µm –0.65 0.22 0.01 0.91
SC1 –0.59 0.39 0.16 0.98
MC 0.1–0.3 µm –0.57 0.42 0.19 1.00
MC 0.3–0.8 µm –0.66 0.22 0.00 0.90
MC1 –0.64 0.29 0.06 0.94
temp_mean –0.25 –0.33 –0.47 –0.07
hum_mean –0.67 –0.11 –0.41 0.40
aCorrelation coefficients between 0.61 and 0.80 are highlighted in light gray and thos
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-
;
measurements of one urban background station to characterize expo-
sure over an entire community. However, concurrent measurements
of particles in the ultrafine range at different sites within one city
often have shown good correlations over time despite differingeter
SC 0
µm
1.00
0.97
0.92
1.00
0.99
0.04
0.56
e bet
47magnitudes in space. This suggests that a background site might
well represent the exposure of the average population with respect
to UFP if the site is carefully chosen (Aalto et al., 2005; Cyrys et al.,
2008; Peters et al., 2005; Puustinen et al., 2007). To the extent that
there is classical measurement error inherent, it has been shown
that it is highly unlikely to bias away from the null even in the pres-
ence of covariates (Zeger et al., 2000). Therefore, measurement error
in our particle metrics would likely attenuate the true association.
As one would expect greater exposure misclassification by a single
monitoring site for locally produced particles such as UFP than for re-
gionally transported particles, the fact that the present study did iden-
tify larger associations between locally generated particles and
cardiovascular mortality, compared to MC in the accumulation mode
range or PM1, point to an important role of locally produced particles
on daily mortality.
We used a variety of particle metrics for the analyses as different
metrics may point toward differing properties of the aerosol and
also represent different sources of air pollution. However, by testing
a set of particle metrics the possibility that some effects might have
occurred by chance cannot be excluded. Because some of the metrics
are closely correlated, we considered especially consistent patterns
in the data as actual effects.5. Conclusions
This analysis showed an elevated risk of cardiovascular mortality
in Beijing from short-term exposure to particulate air pollution in
the sub-micrometer range. Results especially point to a delayed asso-
ciation between particle NC and cardiovascular mortality. Results also
indicate that locally produced ultrafine particles and regionally trans-
ported ACP may exhibit different effects in Beijing.Disclosure statement
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measurements.Appendix As in Beijing, China, for the study period March 2004 to August 2005a.
.3–0.8 SC1 MC 0.1–0.3
µm
MC 0.3–0.8
µm
MC1 temp_mean
1.00
0.98 1.00
0.96 0.92 1.00
0.99 0.96 0.99 1.00
–0.03 –0.05 0.05 0.02 1.00
0.47 0.42 0.57 0.53 0.37
ween 0.81 and 1.00 are underlined and highlighted in light gray.
Table A.2
Sensitivity analyses. Percentage of change (95%-confidence interval) in cardiovascular (ICD-10 I00-I99) per an interquartilea increase in Aitken mode particles and NC1 (b0.8 μm) in
Beijing, from March 2004 to August 2005b.
Type of sensitivity analysis % Change (95% CI) for Aitken mode particles % Change (95% CI) for NC1 (b0.8 μm)
Original model 4.04 (1.18;6.98) 4.92 (1.50;8.45)
More DF (DF=11) for smooth function of trend 3.74 (0.88;6.69) c 4.18 (0.70;7.77) c
More DF (DF=5) for smooth functions of meteorological variables 4.32 (1.39;7.34) 5.76 (2.32;9.32)
Use of apparent temperature instead of mean air temperature 4.21 (1.35;7.16) 5.32 (1.90;8.86)
Excluding days with dust events 3.81 (0.90;6.80) 4.71 (1.26;8.27)
aInterquartile range for Aitken mode (0.03–0.1 μm): 6250 cm−3; NC1: 13,790 cm−3.
bModels adjusted for trend, weekday, temperature (2-day average and 15-day average), and relative humidity (lag 0).
cThe absolute value of the sum of the partial autocorrelation function (PACF) was around −0.78, so there was a large amount of overfitting in this model.
Fig. A.1. Map of Beijing administrative area (light gray) and Beijing urban area (dark gray).
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Abstract 
Background 
Although short-term exposure to ambient particulate matter has increasingly been linked with 
cardiovascular diseases, it is not quite clear how physical characteristics of particles, such as 
particle size may be responsible for the association. This study aimed at investigating whether 
daily changes in number or mass concentrations of accurately size-segregated particles in the 
range of 3nm to 10µm are associated with daily cardiovascular emergency room visits in 
Beijing, China. 
Methods 
Cardiovascular emergency room visit counts, particle size distribution data, and 
meteorological data were collected from Mar 2004 to Dec 2006. Particle size distribution data 
was used to calculate particle number concentrations (NC) in different size fractions, which 
were then converted to particle mass concentrations (MC) assuming spherical particles. We 
evaluated cumulative associations between cardiovascular emergency room visits (ERVT) 
and particle NC and MC using polynomial distributed lag (PDL) models and multi-day 
moving average (8-day, lags 0-7) of particle concentrations. Effects were considered linear 
and presented as relative risks (RR) of ERVT per interquartile range (IQR) increase in particle 
concentrations, together with 95% confidence intervals (CI). 
Results 
We observed delayed associations between NC of ultrafine particles (UFP) and ERVT, mostly 
contributed by particles in the size ranges of 10-30nm and 30-50nm. The RRs (95% CI) of 
ERVT associated with an IQR increase in 8-day moving average NC of UFP, 10-30nm 
particles and 30-50nm particles (9450cm-3, 3248cm-3 and 2076cm-3) were: 1.12 (1.05, 1.19), 
1.13 (1.06, 1.20) and 1.09 (1.03, 1.15), respectively. The PDL curves for the effects of NC 
and MC of 100-300nm or 300-1000nm particles on ERVT showed to be similar. 
Conclusions 
Elevated sub-micrometer particles NC were associated with increased cardiovascular 
morbidity. UFP showed delayed associations, while the harmful effects of 100-1000nm 
particles were immediate. Using particle NC or MC didn’t seem to affect the particle effects. 
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Background 
Ambient particulate matter (PM) has increasingly been linked with cardiovascular 
diseases (CVD) during the last decades [1]. Observed effects of short-term fluctuations of 
ambient PM on the cardiovascular system include ischemia and arrhythmia in patients with 
coronary artery disease, altered heart rate and autonomic control, altered blood pressure, 
systemic inflammatory response, a pro-thrombotic state and endothelial dysfunction [2]. The 
exposure-response functions between short-term exposure to PM and cardiovascular mortality 
and morbidity are generally considered to be near-linear and without a threshold [3], 
indicating that even quite low concentrations of PM could result in adverse influence. 
Different size fractions of PM are under investigation: PM with an aerodynamic 
diameter smaller than 10µm (PM10) or 2.5µm (PM2.5 or fine particles), PM with diameters 
between 2.5µm and 10µm (coarse particles), as well as particles smaller than 100nm (ultrafine 
particles, UFP) [1]. Both subcategories of PM10 (coarse and fine particles) showed short-term 
effects on cardiovascular mortality or morbidity [4]. Some findings suggested that the 
associations were stronger for finer than for coarser particles, or the effects of coarse particles 
on short-term total mortality no longer existed after adjusting for fine particles in a two-
pollutant analysis [4-7]. A possible explanation for the stronger associations between fine 
particles and CVD is that they are deposited on the bronchial tree and alveoli; UFP are even 
able to cross over into the bloodstream [8]. The direct stimulation of blood vessels, as well as 
the particle-induced pulmonary reflexes and pulmonary inflammation, eventually leading to 
arrhythmia or myocardial ischemia, are all considered as possible biological mechanisms 
linking PM with CVD [1]. 
UFP are most often measured by number per cubic centimetre [9]; their high particle 
number concentration and large active surface area (plus small size), thus high deposition 
efficiency in the pulmonary region, make them a great contributor to the observed 
cardiovascular effects [10, 11]. PM10, PM2.5 and coarse particles are typically measured by 
their mass per volume of air (µg/m3) [9]. Meteorological conditions (such as air humidity) can 
modify the spectrum of the size fractions with consequences to health effects [12]. 
Due to the limited availability of appropriate measurement data, there are only few 
epidemiological studies on the short-term effects of more accurately size-segregated particles 
on daily cardiovascular mortality or morbidity [13-17]. Most studies about health effects of 
smaller particles have been conducted in North America or Europe; there is a relative lack of 
studies on Asian population. Different air pollution mixtures and levels in Asian areas might 
influence the associations between human health and air pollution.  
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This study aimed at investigating whether daily changes in ambient concentrations of 
particle size fractions in the range of 3nm to 10µm are associated with cardiovascular 
emergency room visits in Beijing, China. Moreover, we aimed to better delineate whether 
using particle number or mass concentration may affect the associations.  
Material and methods 
Study area and period 
We conducted this study in Beijing, China, from 4 Mar 2004 to 31 Dec 2006 (1033 
days). Beijing has an area of about 16,808km2 consisting of eight urban and ten suburban 
districts (Figure 1), with a population size of approximately 15,380,000 in 2005 
(http://baike.baidu.com/view/2621.htm). It is located in the North China Plain surrounded by 
mountains of 1000-1500m in altitude to the west, north, and northeast, and the Bohai Sea on 
the southeast side. Typical warm temperate semi-humid continental monsoon climate leads to 
hot, humid summers and cold, dry winters. Springs and autumns are both of relatively short 
duration. 
Emergency room visit data 
We obtained standard medical record forms from the Emergency Department of 
Peking University’s Third Hospital, which is located in the Haidian District (Figure 1). Only 
the forms of patients who visited and left the emergency room within one day were available; 
the forms of patients with more severe problems who were transferred to the In-patient 
Department were not available for our database as their forms were transferred together with 
the patients. A database including diagnosis and date of visit based on information in the 
forms was built by medically trained students from Peking University – Health Science 
Center (School of Public Health). The diagnoses were coded according to the International 
Classification of Diseases 10th Revision (ICD-10), and comprised cases of ischemic heart 
diseases (I20-I25), arrhythmia (I47-I49), heart failure (I50), cerebrovascular diseases (I60-
I69), and other diseases within the I00-I99 category as well as cause-unknown sudden death 
(R96). We combined all cases as “total circulatory emergency room visits (ERVT)”. 
Moreover, we combined the first four sub-categories (cases of ischemic heart diseases, 
arrhythmia, heart failure, and cerebrovascular diseases), which are more severe or even fatal, 
as “severe cardiovascular emergency room visits (ERV)”. 
Meteorological data 
We obtained meteorological data including daily mean temperature, relative humidity, 
and barometric pressure from the China Meteorological Data Sharing Service System (station 
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54511, located at N39°48’ E116°28’ in the south eastern part of Beijing within Daxing 
District, see Figure 1). 
Particle concentration data 
Particle size distribution data were sampled on top of a six-floor building inside the 
campus of Peking University, which is also located in the Haidian District (Figure 1). The 
setup of the measurement station is described in detail elsewhere [18, 19]. The measurement 
station is a few hundred meters away from major roads (no heavy traffic) and about 20m 
above ground. The campus is a primarily residential and commercial area without industrial 
sources or agricultural activities. Local emission sources within a radius of 1km could be 
vehicular traffic, fuel combustion for domestic cooking and heating, and construction. An 
earlier examination of the spatial variability of PM2.5 mass and chemical composition in 1999 
to 2002 showed only minor differences between the campus site and a downtown site [18-20]. 
Furthermore, average particle number size distributions at the Peking University measurement 
site and another regional measurement site, located around 50km to the south of the PKU, 
were shown to be similar in summer [21], confirming that the measurement site may be 
considered as an urban background station. 
Aerosol number size distributions were continuously measured between 3nm to 10µm. 
Measurements were done by a Twin Differential Mobility Particle Sizer (TDMPS) which 
covered the size range from 3nm to 800nm (mobility diameter, Dp) [22], and an Aerodynamic 
Particle Sizer (APS, TSI model 3221) which covered the size range from 800nm to 10µm 
(aerodynamic diameter). The data were corrected for losses due to diffusion and 
sedimentation within the inlet line as described by Wehner et al. (2004) [19]. 
Data on number size distributions were used to calculate particle number 
concentrations (NC, cm-3). These data were converted to particle mass concentrations (MC, 
μg/m3) assuming spherical particles with a mean particle density of 1.5g/cm3. The assumption 
of this density was based on previous measurements of chemical compositions of particles in 
Beijing [18, 20]. 
We calculated daily mean NC and MC for the size fractions (nm) 3-10, 10-30, 30-50, 
50-100, 100-300, 300-1000, 1000-2500 and 2500-10000; also for 3-100 (ultrafine particles, 
UFP), 3-1000 (PM1), 3-2500 (PM2.5) and 3-10000 (PM10). Because number and mass can 
better describe and are more common for sub-micrometer and larger particles’ concentrations, 
also that in our study the NC of particles >1µm and the MC of particles <100nm were 
neglectable in comparison to other fractions (data not shown), we excluded those fractions 
from the analyses. So we excluded NC of PM2.5 and PM10, and MC of UFP as well. 
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Statistical analyses 
We used generalized semi-parametric Poisson regression to model the natural 
logarithm of the expected daily emergency room visit counts as a function of the predictor 
variables. Penalized splines were used to allow for non-linear confounding. Data were 
analyzed using the package “mgcv” version 1.4-1.1 in the statistical software R version 2.7.2 
(R Development Core Team, 2008). 
In a first step, a base model was built for ERVT and ERV separately, without particle 
exposure (Supplemental table 1). To control for systematic variation over time, we considered 
long-term time trend as well as dummy variables for season (spring-April to May, summer-
June to August, autumn-September to October, winter-November to March) 
(http://www.bast.net.cn/kjhd/kxpj/kprx/2005/11/7/47746.shtml), day of the week (DOW, 
Monday to Sunday), and public holidays (holiday versus non-holiday) as potential 
confounders. As potential meteorological confounders we considered daily mean temperature, 
relative humidity and barometric pressure. To ensure sufficient adjustment, trend, daily mean 
temperature and relative humidity were forced into all models. Season, DOW, public 
holidays, and barometric pressure were only included if they improved model fit. 
Meteorological confounders were included with the same lag pattern as the particle exposure 
term we used (see next paragraph), except that in the PDL models (see next paragraph), the 
meteorological confounders were always included with the 15-day moving average (MA) of 
lags 0 to 14. The minimization of the absolute value of the sum of the partial autocorrelation 
function (PACF) of the model’s residuals for a fixed number of lags was used to guide the 
selection of degrees of freedom (DF) for trend [23]. Model selection for the other confounder 
variables was carried out by minimizing the Generalized Cross Validation (GCV) criterion 
[24]. 
We investigated the cumulative lagged effects of particles (also both NC and MC) of 
each size fraction up to 15 days, by applying polynomial distributed lag (PDL) models [25]. 
PDL models could avoid problems related to co-linearity among lagged exposure variables; 
we constrained the shape of the distributed lag curve to follow a polynomial of 5th-order in 
order to get a flexible functional form. Furthermore, according to the PDL curves we obtained 
(showed in the results section) and a further study [14], we considered 8-day (lags 0 to 7) MA 
of NC and MC in different size fractions as exposure terms. We added all particle metrics 
separately to the base models and estimated associations linearly [3]. Effect estimates are 
presented as relative risks (RR) of ERVT or ERV together with 95% confidence intervals (CI) 
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based on an increase in NC or MC from the first to the third quartile (interquartile range 
[IQR]). 
Sensitivity analyses 
To explore the robustness of the models, we forced daily mean barometric pressure 
into the base models additionally (always with the MA of lags 0 to 14 in PDL models, or the 
same lag pattern as the particle exposure term in Poisson regression models) and then re-
analyzed the particle effects. Moreover, for PDL models we varied the degree of the 
polynomial order; for Poisson regression models we changed smoothing parameter for the 
time trend functions. Furthermore, we explored the exposure-response functions between 8-
day MA of NC or MC and ERVT or ERV to check the assumption of linearity by including 
these particle concentration terms as penalized splines in the models as well, as air pollution 
levels are much higher in Beijing (compared to other studies in the U.S. and Europe). 
Results 
Emergency room visit data and meteorological data 
Table 1 presents the overall ERVT and ERV counts during the study period, as well as 
descriptive statistics for daily ERVT, ERV, temperature, relative humidity, and barometric 
pressure. ERV counts represented 67% of the ERVT counts. As shown in Supplementary 
figure 1, daily temperature, relative humidity and barometric pressure all followed seasonal 
patterns, but with different directions and magnitudes. We could not confidently detect a 
seasonal pattern within ERVT or ERV data; in contrast, daily cardiovascular death counts 
data of Beijing urban area was reported to follow a seasonal pattern [26]. 
Particle concentration data 
Table 2 presents the descriptive statistics for daily NC and MC in different size 
fractions. According to time-series plots (data not shown), particle concentrations of all size 
fractions were higher in colder periods and lower in warmer periods. Clear seasonal patterns 
(peak in winter and trough in summer) could be seen for NC of 3-10nm, 50-100nm and 100-
300nm particles, as well as for MC of 100-30 nm particles. There was a decline from 2004 to 
2006 in NC of 3-10nm, 10-30nm and 30-50nm particles, as well as in NC of UFP and PM1. 
Spearman rank correlations among NC/MC of all size fractions are shown in Supplemental 
table 2. As expected, NC of size fractions within the Nucleation mode range (<30nm), within 
the Aitken mode range (30-100nm) and within the accumulation mode range (100-1000nm), 
respectively, were highly correlated with each other. Particle NC within different mode range 
fractions were not substantially correlated. Modest negative correlation has also been seen 
between the smallest size fraction of 3-10nm and the size fraction 300-1000nm. Again as 
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expected, MC of size fractions within the accumulation mode range were highly correlated 
with each other. And modest correlations were seen between MC of 1000-2500nm and 100-
300nm as well as 300-1000nm particles. The NC and MC of the two size fractions within the 
accumulation mode range were also highly cross-correlated with each other. Modest 
correlation could be seen between NC of 3-10nm and MC of 300-1000nm particles (negative), 
and between NC of 50-100nm and MC of 100-300nm particles, in agreement with what 
mentioned for NC of 100-300nm and 300-1000nm particles above. Modest correlation could 
also be seen between NC of 300-1000nm and MC of 1000-2500nm particles. 
Regression results 
Figure 2, Figure 3, Supplementary figure 2 and Supplementary figure 3 present the 
PDL curves of ERVT and ERV for the IQR-increases of NC or MC of each particle size 
fraction. The shapes of the curves for ERVT and ERV with the same particle metrics and 
particle size fraction were very similar, with the ones of ERV having broader 95% CI, 
probably due to fewer ERV cases compared with ERVT. 
The increase of NC of the four size fractions smaller than 100nm showed delayed 
harmful effects on ERVT and ERV, among which the effects of 10-30nm particles were 
strongest and longest, from lag4 to lag10, while the effect of 50-100nm particles did not reach 
statistical significance. The increase of NC of the four size fractions within the range 30-
1000nm may also point to current-day immediate effects on ERVT and ERV. Delayed and 
current-day immediate effects could also be seen with the increase of NC of UFP and PM1. 
Note, however, that the effects with these two larger size fractions here actually referred 
especially the two size fractions 10-30nm and 30-50nm. 
The rises of MC of all size fractions, together with the rises of NC of 100-300nm and 
300-1000nm particles, showed a similar shape with delayed “protective” effects on ERVT and 
ERV, mainly from lag10 to lag13. However, we would rather refer them as morbidity 
displacements (harvesting) after harmful effects of particulate air pollution. The harmful 
effects of the increase of MC mostly appeared at lag0 and lasted until lag2, although all 
without statistical significance. 
Table 3 and Supplementary table 3 present the quantitative RRs (95% CI) of ERVT 
and ERV associated with 8-day MA of NC or MC. Significant effects ranged between 4 and 
13% increase in RR. For most size fractions, the magnitude of the harmful effect on ERVT 
was higher than the one on ERV; the only exception was the size fraction 3-10nm. 
Sensitivity analyses 
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Forcing daily mean barometric pressure additionally into the base models did not 
substantially change the shapes of the PDL curves or the RRs (95% CI) (data not shown). 
After varying the degree of polynomial order of the PDL models from 5 to 4, 3 or 6, the PDL 
curves kept similar trends, but became smoother or rougher; the curves of MC were more 
affected than the curves of NC (data not shown). Changing the smoothness for the function of 
time trend in the Poisson regression models to a smaller value induced changes on some 
particle effects’ magnitudes but not on directions; changing the smoothness to a bigger value 
made almost no change in particle effects (data not shown). Figure 4 and 5 present the 
exposure-response functions for ERVT associated with the 8-day MA of NC or MC of each 
particle size fraction. Looking at the fragment with most of the NC or MC data of each 
exposure-response function plot, only the function associated with the 8-day MA of NC of 3-
10 nm particles seemed to show a J-shape; the other functions did not substantially deviate 
from linearity. The exposure-response functions for ERV were similar (data not shown). 
Discussion 
Summary 
In our study UFP NC as well as NC in the four UFP size fractions showed delayed 
associations on ERVT and ERV. Strongest effects were seen for the size class 10-30nm. The 
harmful effects of the rises of MC mostly appeared at lag0 and lasted until lag2. Regarding 
each size fraction, the harmful effect of particles on ERVT was in most cases higher than the 
effect on ERV, except for the NC of 3-10nm particles. 
Effects of sub-micrometer (<1000nm) ambient particles 
Using particle data from the same measurement station, Breitner et al. (2011) [26] 
reported 2-days delayed associations between daily cardiovascular mortality in the Beijing 
urban area and NC of Aitken mode particles and particles smaller than 800nm. In a study 
conducted in London by Atkinson et al. (2010) [13], the associations between particle NC and 
cardiovascular death and emergency hospital admissions were observed at lag 1 and lag 2, 
respectively. In studies conducted in Erfurt, Germany, an increase in NC of 10-30nm particles, 
30-50nm particles and UFP at lag 4 were associated with the most increased risk for daily 
mortality [16-17]. In our study on cardiovascular ERV, the “best single-day lag” appeared to 
be lag 7, suggesting that the effects of sub-micrometer particles (measured in NC) on hospital 
admission may (although not always) appear later (with more lag days) than the effects on 
death. 
Branis et al. (2010) [14] reported that in Prague, Czech Republic, the 7-days moving 
average of NC of Aitken mode, accumulation mode and total submicron particles all elevated 
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the number of cardiovascular hospital admissions. The RRs associated with an increase of 
1000 particles/cm3 were 1.018 (95%CI: 1.007-1.029), 1.164 (95%CI: 1.052-1.287) and 1.011 
(95%CI: 1.004-1.018), respectively. They also reported significant associations between 
cardiovascular hospital admissions and NC of Aitken mode, accumulation mode and total 
submicron particles at lag 0, comparable to what we found. When re-calculating our data on 
the base of 1000 particles/cm3 increase in 8-day MA of NC, the RRs for ERVT associated 
with 30-50nm, 50-100nm, 100-300nm, 300-1000nm as well as 3-1000nm particles were 1.043 
(95% CI: 1.014-1.072), 1.018 (95% CI: 1.000-1.036), 1.004 (95% CI: 0.989-1.019), 0.978 
(95% CI: 0.913-1.044) and 1.010 (95% CI: 1.004-1.017), respectively. Halonen et al. (2009) 
[15] investigated the associations between NC of Nucleation mode, Aitken mode and 
accumulation mode particles and acute hospital admissions of a population aged 65 years or 
older due to coronary heart disease (CHD), stroke and arrhythmia in Helsinki, Finland. They 
found that only the 5-day average NC of Aitken mode particles was significantly associated 
with arrhythmia admission with a RR of 1.041 (95% CI: 1.003-1.080) per an increase of 2467 
particles/cm3. Arrhythmia admission accounted for 20% ERV in our study; we found an 
increase in ERV admissions of 1.07 (95% CI: 1.00-1.14) per 2076/cm3 increase in 8-days MA 
of NC of 30-50nm particles. On the other hand, Andersen et al. (2008) [27] failed in finding 
any significant associations between NC of 6-700nm particles or UFP and cardiovascular 
admissions of elderly people (≥65 years) in Copenhagen, Denmark. 
Only very few studies have used MC of accumulation mode or sub-micrometer 
particles, mainly focusing on cardiovascular mortality rather than cardiovascular hospital 
admission. Breitner et al. (2011) [26] reported an increased ischemic heart disease mortality 
associated with increases in lag 2 MC of 100-300nm, 300-800nm and <800nm particles in 
Beijing, China. Perez et al. (2009) [28] found increases in cardiovascular and cerebrovascular 
mortality associated with an increase in lag 1 MC of PM1 in a study conducted in Barcelona. 
In a study conducted in Spokane, Washington, cardiac emergency room visits and hospital 
admissions were considered, but no consistent associations between them and MC of PM1 
were found [29]. In our study, the increased cardiovascular morbidity were mainly associated 
with the increases in lag 0 to 1 MC of particles <1000nm. 
Effects of 1000-2500nm ambient particles and fine particles 
A number of epidemiologic studies have examined the adverse effect of fine particles 
on cardiovascular morbidity [30-33]. Guo et al. (2010) [30] explored the risk of hypertension 
emergency hospital visits in Beijing, China associated with fine particles. They reported an 
odds ratio (overall effect of five days) of 1.084 (95% CI: 1.028-1.139) associated with a 
61
10μg/m3 increase in PM2.5. Jalaludin et al. (2006) [31] found in Sydney, Australia, the 
percentage changes of all CVD attendances associated with an increase of 4.8μg/m3 in lag 0 
or lag 0-1 average PM2.5 were 1.26% (95% CI: 0.56-1.96%) and 0.85% (95% CI: 0.18-1.52%), 
respectively. According to Figure 3, the percentage change of ERVT associated with an IQR 
increase in lag 0 or lag 1 MC of PM2.5 in our study was about 1.00%; however, our IQR value 
was 94.5μg/m3. This largely different IQR in fine particle MC versus the observed similar 
changes in cardiovascular emergency visit counts might give a hint on possible population 
adaptation to air pollution in Beijing (although the linearity of effects doesn’t point towards 
an adaptation). There is a lack of time-series study exactly examining the adverse effect of 
1000-2500nm particles (PM2.5-1) on cardiovascular hospital admission. But two panel studies 
[34, 35] have shown that increased PM2.5-1 (MC) could raise the risk of arterial stiffness and 
heart rate variability (HRV) reduction. Moreover, morbidity displacement of PM2.5 was also 
reported by Belleudi et al. (2010) [36], but for chronic obstructive pulmonary disease (COPD) 
hospital admission. 
Effects of coarse particles and PM10 
A large number of epidemiologic studies have examined the adverse effect of PM10 on 
cardiovascular health outcomes [37]. The short-term (time lag: 0-5 days) effects of PM10 were 
seen on cardiovascular diseases hospital admission of people of every age group; however, 
the effect size varied a lot (even within each age group) [38]. The percentage changes in the 
admission associated with per 10μg/m3 increase in PM10 ranged from 0.50% to 4.80% [38]. 
With regard to coarse particles and cardiovascular morbidity, Peng et al. (2008) [6] reported 
an association between a 10μg/m3 increase in PM10-2.5 in the United States and a 0.36% (95% 
CI: 0.05-0.68%) increase in cardiovascular disease admission on the same day. Host et al. 
(2008) [39] reported an association between a 10μg/m3 increases in PM10-2.5 in six French 
cities and increases in ischemic heart disease hospitalization of elderly people (6.4% (95% CI: 
1.6-11.4%). Besides, two studies [40, 41] conducted on the base of repeatedly measured data 
of certain group of subjects also reported that increase in coarse particles concentration was 
associated with increased risk of systemic inflammation and decreased HRV. In contrast, Kan 
et al. (2007) [5] did not find a significant effect of coarse particles on CVD mortality in 
Shanghai, China. According to Figure 2, the percentage changes of ERVT associated with the 
IQR increases in lag 0 MC of PM10 and PM10-2.5 in our study were about 1.20% and 1.10%, 
respectively (IQR: PM10 116.1μg/m3 and PM10-2.5 21.6μg/m3, respectively). 
Strengths and limitations 
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This study was conducted in a highly polluted city and based on data of accurately 
size-segregated particles. The emergency room visit data was collected from Peking 
University’s Third Hospital, located in the Haidian district, where patients within 10 km of 
the measurement site were likely to be treated (personal communication with hospital doctors) 
[20]. As the urban area of Beijing is 1,368km2 with about 7,072,000 registered permanent 
residents in 2005 [42], this area about 314km2 then contained approximately 1,623,251 
permanent residents. The daily ERVT count reached 13, ensuring the statistical power of the 
analysis. About 20% (randomly chosen 4-5 days per month) of the emergency room visit 
information were double entered; the identity of the numeric content between the two entries 
was higher than 90%. Assignments of the diagnoses to ICD-10 disease categories (done by 
the investigators) were quality assured by a nosological expert from the Third Hospital 
(percentage of misclassification was about 4%). These two steps assured good quality of 
emergency room visit data. 
Nevertheless, this study also has some limitations. We collected particle data from 
only one measurement site; therefore, measurement error due to greater spatial variability of 
Beijing could be present in this study, especially for numbers of traffic-associated particles. 
Nevertheless, the average particle number size distributions at the Peking University 
measurement site and another regional measurement site located around 50km to the south of 
the University were shown to be comparable [20]. Moreover, the Peking University 
measurement site and the Third Hospital were quite near to each other (see Figure 1); so the 
measurement site is assumed to have measured the average exposure of the district. On the 
other hand, we collected emergency room visit data also from only one hospital, and only 
patients within a certain area of Beijing (patients within 10km of the measurement site, as 
mentioned above) were likely to be treated there. This area is an urban area, has no substantial 
difference from other areas of the urban part of Beijing, except that many universities are 
located there. Therefore, it can be speculated that the education level and socioeconomic 
status (SES) of the population of this area might be higher than the average level of the whole 
Beijing urban area. Moreover, due to too many missing records in age and gender, we were 
not able to investigate particle effects by age or gender subgroups. 
Conclusions 
The results from our study add to the evidence that elevated concentrations of sub-
micrometer particles are associated with increased cardiovascular morbidity. UFP showed 
delayed associations, while the harmful effects of 100-1000nm particles were rather 
immediate. This might indicate that particles of different size ranges play their effects through 
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different pathways. The different lags by which the effects of certain particle size fractions 
appear should be considered when taking preventive measures to improve public health. 
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Table 1. Descriptive statistics of daily emergency room visit counts, daily mean 
temperature, relative humidity, and barometric pressure 
     
                        Total        Mean ± SD     Min   Median   Max         
 
ERVT a                  13026          13 ± 5        1      12       30 
ERV b                    8698           8 ± 4        1       8       24 
 
Temperature (°C)                       )14.2 ± 10.7    -10.1    16.4     32.1 
Relative humidity (%)                     53 ± 20       )8      54       93  
Barometric pressure (hPa)                1012 ± 10       988    1012    1043 
 
    a. ERVT = Cardiovascular diseases (I00-I99) + Cause-unknown sudden death (R96) 
    b. ERV = Ischemic heart diseases (I20-I25) + Arrhythmia (I47-I49) + Heart failure (I50)   
            + Cerebrovascular diseases (I60-I69) 
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Table 2. D
escriptive statistics of daily m
ean particle num
ber concentrations (N
C
) and m
ass concentrations (M
C
) 
 Size fraction  M
issing                 N
C
 (cm
-3)                             M
C
 (μg m
-3)  
   (nm
)       (%
) 
(nm
)       (%
)      M
ean±SD
    M
in  M
edian  M
ax       M
ean±SD
    M
in  M
edian  M
ax          
 
    3-10          7.0      3367 ± 4250    85   1804   40703                      
a       
    10-30         7.0      6732 ± 3736  1182   5862   29914                      
a       
    30-50         7.0      4890 ± 1839   893   4691   13608                      
a       
    50-100        7.0      6792 ± 2881   634   6454   19393                      
a       
    100-300       7.0      6430 ± 3583   337   5904   21169       29.3 ± 18.3    1.4    26.2   105.1 
    300-1000     18.8       882 ± 725     28    712    4775       62.0 ± 52.6    2.2    49.4   323.9 
    1000-2500    18.8                     
a                      
.16.4 ± 15.0    0.3    12.7   139.4 
    2500-10000   18.8                     
a                      
.23.7 ± 21.4    0.4    18.4   222.0 
    3-100         7.0     21781 ± 9616   5612  19622  76283                      
a         
    3-1000       18.8     29297 ± 10226  7441  27624  86864       93.4 ± 68.6    3.8    80.0   412.5 
    3-2500       18.8                     
a                     
.109.8 ± 77.9    7.8    92.9   451.5 
    3-10000      18.8                     
a                     
.136.4 ± 93.3   11.4   117.0   539.0 
 
a. N
eglectable, therefore excluded from
 analyses
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Table 3. R
elative risks (R
R
) (together w
ith 95%
 confidence intervals (C
I)) for ER
V
T per 
interquartile range (IQ
R
) increase in 8-days M
A of N
C
 or M
C
. N
C
 or M
C
 of each size 
fraction and each lag term
 w
as added individually to the base m
odels linearly. 
     
  Size fraction             N
C
 (cm
-3)                      M
C
 (μg m
-3) 
     (nm
)           
                   IQ
R
   R
R
 (95%
C
I) for E
R
V
T    IQ
R
   R
R
 (95%
C
I) for E
R
V
T
 
 
 3-10             2800    1.04 (1.00, 1.09) *                     
 10-30            3248    1.13 (1.06, 1.20) *         
 30-50            2076    1.09 (1.03, 1.15) *        
 50-100           2777    1.05 (1.00, 1.10) *        
 100-300          2694    1.01 (0.97, 1.05)         
) 12.5    1.00 (0.96, 1.04)           
 300-1000          458    0.99 (0.96, 1.02)          33.4    0.99 (0.96, 1.02)           
 1000-2500                                      ) 10.2    1.01 (0.99, 1.04)          
 2500-10000                                     ) 16.1    1.02 (0.98, 1.05)          
  3-100            9450    1.12 (1.05, 1.19) *        
 3-1000          11270    1.11 (1.04, 1.19) *        46.6    0.99 (0.96, 1.02)          
  
 3-2500                                          51.4    1.00 (0.96, 1.03)          
  
 3-10000                                         64.7    1.00 (0.97, 1.03)            
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Figure 1. Beijing (shaded area is the urban area) and the locations of data sources. 
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Figure 2. Relative risks (RR, together with 95% confidence intervals (CI)) for ERVT in 
association with an interquartile range (IQR) increase in NC or MC of each particle size 
fraction, excluding UFP, PM1, PM2.5 and PM10, obtained with polynomial distributed lag 
models. Models were estimated with lags up to 15 days using a fifth degree polynomial. 
Indicated in each plot are the overall 15-day relative risks.  
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ith
 95%
 con
fid
en
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R
V
T
 in association
 w
ith
 an
 in
terq
u
artile ran
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R
) 
in
crease in
 N
C
 or M
C
 of U
F
P
, P
M
1 , P
M
2.5  an
d
 P
M
10  ob
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 w
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 p
olyn
om
ial distrib
u
ted
 lag m
od
els. M
od
els w
ere estim
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 w
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lags u
p
 to 15 d
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sin
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 d
egree p
olyn
om
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d
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 in
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 p
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ay relative risk
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Figure 4. Exposure-response functions (together with 95% confidence intervals) for daily 
ERVT associated with 8-day MA of NC or MC of each particle size fraction, excluding UFP, 
PM1, PM2.5 and PM10. 
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Figure 5. Exposure-response functions (together with 95% confidence intervals) for daily 
ERVT associated with 8-day MA of NC or MC of UFP, PM1, PM2.5 and PM10. 
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Supplem
entary table 1. C
onfounders included in each base m
odel * 
 
                                                                                                                                     C
onfounders 
              E
R
V
T or E
R
V
 
                                                    trend                     season           day of the w
eek  (D
O
W
)     public holidays         tem
perature          relative hum
idity              
               E
R
V
T
                 penalized spline        dum
m
y variable         dum
m
y variable             dum
m
y variable        penalized spline        penalized spline 
              E
R
V
                    penalized spline        dum
m
y variable         dum
m
y variable             dum
m
y variable        penalized spline        penalized spline 
 
 * A
s one sensitivity analysis, w
e forced barom
etric pressure into the base m
odels by penalized spline additionally.  
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Supplementary figure 1. Daily ERVT, ERV, temperature, relative humidity and barometric 
pressure 
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Supplem
entary table 2. Spearm
an rank correlations a 
     
                                       N
C
 (cm
-3)                                                                   M
C
 (μg m
-3) 
                                       3-10  10-30  30-50  50-100  100-300  300-1000        100-300  300-1000  1000-2500  2500-10000                                 
     N
C
          3-10               1 
   (cm
-3)      10-30            0.87      1              
               30-50            0.34    0.63       1                
               50-100         -0.09    0.19    0.81       1                                           
               100-300       -0.51   -0.28    0.33     0.74           1                              
               300-1000     -0.67   -0.48    0.05     0.43         0.87         1                                       
 
    M
C
        100-300       -0.57  -0.35     0.23     0.63         0.98       0.93              1                                                                    
   (μg m
-3)  300-1000     -0.66  -0.48     0.04     0.42         0.84       0.99            0.91           1                                                                          
               1000-2500   -0.43  -0.32    -0.04     0.23         0.58       0.71            0.63         0.74              1                                                                                        
               2500-10000 -0.14  -0.06     0.16     0.31         0.49       0.51            0.51         0.52            0.79              1                                                                                             
 
 a. C
orrelation coefficients betw
een 0.61 and 0.80 are highlighted in light grey and  
      those betw
een 0.81 and 1.00 are underlined and highlighted in dark grey. 
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Supplementary figure 2. Relative risks (RR, together with 95% confidence intervals (CI)) for 
ERV in association with an interquartile range (IQR) increase in NC or MC of each particle size 
fraction, excluding UFP, PM1, PM2.5 and PM10, obtained with polynomial distributed lag models. 
Models were estimated with lags up to 15 days using a fifth degree polynomial. Indicated in each 
plot are the overall 15-day relative risks.  
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  Supplem
entary figure 3. R
elative risks (R
R
, together w
ith 95%
 confidence intervals (C
I)) for E
R
V
 in association w
ith an interquartile range (IQ
R
) 
increase in N
C
 or M
C
 of U
FP, PM
1 , PM
2.5  and PM
10  obtained w
ith polynom
ial distributed lag m
odels. M
odels w
ere estim
ated w
ith lags up to 15 days 
using a fifth degree polynom
ial. Indicated in each plot are the overall 15-day relative risks. 
    R
R
 / 
IQ
R
 
                              
                                
                                  N
C
 of U
F
P                                           N
C
 of P
M
1                                                                      
                                                                                                                              
                                                                          L
ag 
                                                                                                                          
                                
 R
R
 / 
IQ
R
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C
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M
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C
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M
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C
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 Supplem
entary table 3. R
elative risks (R
R
) (together w
ith 95%
 confidence intervals (C
I)) for 
E
R
V
 per interquartile range (IQ
R
) increase in 8-days or 15-days M
A
 of N
C
 or M
C
. N
C
 or 
M
C
 of each size fraction and each lag term
 w
as added individually to the base m
odels linearly.  
     
  Size fraction                 N
C
 (cm
-3)                                        M
C
 (μg m
-3) 
     (nm
)           
                                                  IQ
R
   R
R
 (95%
C
I) for E
R
V
T      IQ
R
   R
R
 (95%
C
I) for E
R
V
T
 
 
 3-10                  2800     1.06 (1.01, 1.12) *                     
 10-30                3248     1.10 (1.02, 1.18) *         
 30-50                2076     1.07 (1.00, 1.14) *        
 50-100              2777     1.03 (0.98, 1.09)        
 100-300            2694     0.99 (0.95, 1.04)         )       12.5      0.99 (0.95, 1.03)           
 300-1000            458     0.97 (0.93, 1.01)                 33.4      0.98 (0.94, 1.02)           
 1000-2500                                      )                         10.2      1.01 (0.97, 1.04)          
 2500-10000                                     )                        16.1      0.99 (0.95, 1.04)          
 
 3-100                9450    1.10 (1.03, 1.18) *        
 3-1000            11270    1.10 (1.02, 1.19) *               46.6      0.97 (0.93, 1.02)            
 3-2500                                                                      51.4       0.98 (0.94, 1.02)            
 3-10000                                                                    64.7       0.99 (0.94, 1.03)            
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